UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


 


(Mark one)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 20212022

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                         to                         .

 

Commission File Number: 000-24248


g01.jpg

 

logo.jpg

GENASYS INC.

(Exact name of registrant as specified in its charter)


 

Delaware

87-0361799

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification Number)

16262 West Bernardo Drive, San Diego,

California

92127

(Address of principal executive offices)

(Zip Code)

 

(858) 676-1112

(Registrants telephone number, including area code)


Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which securities are registered

Common stock, $0.00001 par value per share

GNSS

NASDAQ Capital Market

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  ☒   Yes     ☐  No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    ☒  Yes    ☐  No

 

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

    

Non-accelerated filer

Smaller reporting company

   

Emerging growth company

  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    ☐  Yes  ☒    No

 

The number of shares of Common Stock, $0.00001 par value, outstanding on July 27, 2021,August 9, 2022 was 36,142,093.36,596,005.

 



 

 

 

PART I. FINANCIAL INFORMATION

Item 1.         Financial Statements

Genasys Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except par value and share amounts)

 

 

June 30,

     

June 30,

    
 

2021

 

September 30,

  

2022

 

September 30,

 
 

(Unaudited)

  

2020

  

(Unaudited)

  

2021

 

ASSETS

  

Current assets:

  

Cash and cash equivalents

 $14,540  $23,319  $11,723  $13,167 

Short-term marketable securities

 5,976  4,265  5,270  5,686 

Restricted cash

 286  282  100  279 

Accounts receivable, net

 6,270  5,442 

Accounts receivable, net of allowance for doubtful accounts of $127

 5,691  7,682 

Inventories, net

 6,422  5,949  8,806  6,416 

Prepaid expenses and other

  1,464   860   1,233   2,255 

Total current assets

 34,958  40,117  32,823  35,485 
  

Long-term marketable securities

 2,297  3,805  2,004  1,875 

Long-term restricted cash

 1,202  395  971  1,082 

Deferred tax assets, net

 10,694  11,095  8,408  8,039 

Property and equipment, net

 1,836  1,930  1,644  1,755 

Goodwill

 23,908  2,472  23,511  23,834 

Intangible assets, net

 13,431  943  11,098  12,804 

Operating lease right of use asset

 5,048  5,285 

Operating lease right of use assets

 4,315  4,862 

Other assets

  193   125   337   392 

Total assets

 $93,567  $66,167  $85,111  $90,128 
  

LIABILITIES AND STOCKHOLDERS' EQUITY

  

Current liabilities:

  

Accounts payable

 $2,708  $1,370  $2,501  $2,160 

Accrued liabilities

 13,305  7,880  11,827  14,111 

Notes payable

 304  300  0  296 

Operating lease liabilities, current portion

  877   771   882   899 

Total current liabilities

 17,194  10,321  15,210  17,466 
  

Notes payable, less current portion

 0  18 

Other liabilities, noncurrent

 5,420  293  975  995 

Operating lease liabilities, noncurrent

  5,952   6,395   5,057   5,709 

Total liabilities

 28,566  17,027   21,242   24,170 
  

Stockholders' equity:

  

Preferred stock, $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding

 0  0  0  0 

Common stock, $0.00001 par value; 100,000,000 shares authorized; 36,142,093 and 33,561,544 shares issued and outstanding, respectively

 0  0 

Common stock, $0.00001 par value; 100,000,000 shares authorized; 36,596,005 and 36,403,833 shares issued and outstanding, respectively

 0  0 

Additional paid-in capital

 106,602  91,248  107,945  107,110 

Accumulated deficit

 (41,925) (41,858) (43,540) (41,154)

Accumulated other comprehensive income (loss)

  324   (250)  (536)  2 

Total stockholders' equity

  65,001   49,140   63,869   65,958 

Total liabilities and stockholders' equity

 $93,567  $66,167  $85,111  $90,128 

 

See accompanying notes

 

1

 

 

Genasys Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share and share amounts)

(Unaudited)

 

 

Three months ended

 

Nine months ended

  

Three months ended

 

Nine months ended

 
 

June 30,

 

June 30,

  

June 30,

 

June 30,

 
 

2021

  

2020

  

2021

  

2020

  

2022

  

2021

  

2022

  

2021

 

Revenues:

  

Product sales

 $10,719  $10,933  $27,800  $26,494  $12,904  $10,719  $34,328  $27,800 

Contract and other

  1,908   1,038   4,156   2,535   1,248   1,908   3,669   4,156 

Total revenues

 12,627  11,971  31,956  29,029  14,152  12,627  37,997  31,956 

Cost of revenues

  5,941   5,500   16,229   13,946   7,572   6,206   19,315   16,556 
  

Gross Profit

  6,686   6,471   15,727   15,083 

Gross profit

  6,580   6,421   18,682   15,400 
  

Operating expenses

  

Selling, general and administrative

 4,776  3,330  11,931  8,884  5,502  4,776  16,133  11,931 

Research and development

  1,390   1,200   3,416   3,233   1,707   1,125   5,314   3,089 

Total operating expenses

 6,166  4,530  15,347  12,117  7,209  5,901  21,447  15,020 
  

Income from operations

 520  1,941  380  2,966 

(Loss) income from operations

 (629) 520  (2,765) 380 
  

Other income (expense), net

  (2)  36   59   202   9   (2)  12   59 
  

Income before income taxes

 518  1,977  439  3,168 

Income tax expense

  228   473   506   742 

Net income (loss)

 $290  $1,504  $(67) $2,426 

(Loss) income before income taxes

 (620) 518  (2,753) 439 

Income tax (benefit) expense

  (31)  228   (367)  506 

Net (loss) income

 $(589) $290  $(2,386) $(67)
  

Net income (loss) per common share:

 

Net (loss) income per common share:

 

Basic

 $0.01  $0.05  $(0.00) $0.07  $(0.02) $0.01  $(0.07) $(0.00)

Diluted

 $0.01  $0.04  $(0.00) $0.07  $(0.02) $0.01  $(0.07) $(0.00)

Weighted average common shares outstanding:

  

Basic

  34,109,167   33,289,426   33,797,774   33,122,042   36,566,900   34,109,167   36,459,179   33,797,774 

Diluted

  35,270,945   34,280,915   33,797,774   33,878,243   36,566,900   35,270,945   36,459,179   33,797,774 

 

See accompanying notes

 

2

 

 

Genasys Inc.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(in thousands)

(Unaudited)

 

  

Three months ended

  

Nine months ended

 
  

June 30,

  

June 30,

 
  

2021

  

2020

  

2021

  

2020

 

Net income (loss)

 $290  $1,504  $(67) $2,426 

Other comprehensive income

                

Unrealized gain (loss) on marketable securities

  1   8   (5)  (3)

Unrealized foreign currency gain

  182   43   579   70 

Comprehensive income

 $473  $1,555  $507  $2,493 
  

Three months ended

  

Nine months ended

 
  

June 30,

  

June 30,

 
  

2022

  

2021

  

2022

  

2021

 

Net (loss) income

 $(589) $290  $(2,386) $(67)

Other comprehensive (loss) income

                

Unrealized (loss) gain on marketable securities

  (12)  1   (81)  (5)

Unrealized foreign currency translation (loss) gain

  (440)  182   (457)  579 

Comprehensive (loss) income

 $(1,041) $473  $(2,924) $507 

 

3

 

 

Genasys Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

 

 

Nine months ended

  

Nine Months Ended

 
 

June 30,

  

June 30,

 
 

2021

  

2020

  

2022

  

2021

 

Operating Activities:

  

Net (loss) income

 $(67) $2,426 

Net loss

 $(2,386) $(67)
  

Adjustments to reconcile net (loss) income to net cash provided by operating activities:

 
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: 

Depreciation and amortization

 953  620  1,920  953 

Amortization of debt issuance costs

 7  0  14  7 

Warranty provision

 44  2  38  44 

Inventory obsolescence

 315  168  174  315 

Share-based compensation

 956  776 

Stock-based compensation

 1,650  956 

Realized loss on foreign currency forward contract

 (48) 0  0  (76)

Unrealized loss on foreign currency forward contract

 (28) 0 

Deferred income taxes

 506  742  (369) 506 

Amortization of operating lease right of use asset

 518  446  543  518 

Accretion of acquisition holdback liability

 34  0  36  34 
  

Changes in operating assets and liabilities:

  

Accounts receivable, net

 (574) (2,722) 1,964  (574)

Inventories, net

 (788) (1,667) (2,563) (788)

Prepaid expenses and other

 (636) 732  1,049  (636)

Accounts payable

 1,134  2,040  371  1,134 

Accrued and other liabilities

  5,988   148   (3,012)  5,988 

Net cash provided by operating activities

  8,314   3,711 

Net cash (used in) provided by operating activities

  (571)  8,314 
  

Investing Activities:

  

Purchases of marketable securities

 (4,457) (5,497) (5,287) (4,457)

Proceeds from maturities of marketable securities

 4,249  3,183  5,492  4,249 

Cash paid for acquisitions net of cash acquired

 (15,848) 0  0  (15,848)

Capital expenditures

  (181)  (111)  (191)  (181)

Net cash used in investing activities

  (16,237)  (2,425)

Net cash provided by (used in) investing activities

  14   (16,237)
  

Financing Activities:

  

Proceeds from exercise of stock options

 170  996  253  170 

Repurchase of common stock

 0  (398) (998) 0 

Shares retained for payment of taxes in connection with settlement of restricted stock units

 (141) (41) (70) (141)

Payments on promissory notes

 (18) (17) (277) (18)

Cash paid for debt issuance costs

  (38)  0   0   (38)

Net cash (used in) provided by financing activities

  (27)  540 

Net cash used in financing activities

  (1,092)  (27)

Effect of foreign exchange rate on cash

  (18)  (9)  (85)  (18)

Net (decrease) increase in cash, cash equivalents, and restricted cash

 (7,968) 1,817 

Net decrease in cash, cash equivalents, and restricted cash

 (1,734) (7,968)

Cash, cash equivalents and restricted cash, beginning of period

  23,996   19,517   14,528   23,996 

Cash, cash equivalents and restricted cash, end of period

 $16,028  $21,334  $12,794  $16,028 
  

Reconciliation of cash, cash equivalents and restricted cash to the consolidated

 

balance sheets:

 
 -  - 

Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:

 

Cash and cash equivalents

 $14,540  $20,668  $11,723  $14,540 

Restricted cash, current portion

 286  271  100  286 

Long-term restricted cash

  1,202   395   971   1,202 

Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows

 $16,028  $21,334  $12,794  $16,028 

 

See accompanying notes

 

4

 

Genasys Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)

(in thousands)

(Unaudited)

 

 

Nine Months Ended

 
 

Nine months ended June 30,

  

June 30,

 
 

2021

  

2020

  

2022

  

2021

 

Noncash investing and financing activities:

  

Change in unrealized loss on marketable securities

 $(6) $(3) $(81) $(6)

Common stock issued in connection with the purchase of Zonehaven

 $(10,938) $0  $0  $(10,938)

Obligation to issue common stock in connection with the Amika Mobile asset purchase

 $(2,703) $0  $(832) $(2,703)

Initial measurement of operating lease right of use assets

 $259  $5,824  $7  $259 

Initial measurement of operating lease liabilities

 $259  $7,815  $7  $259 
  

Business combinations accounted for as a purchase

  

Fair value of net assets acquired

 $30,980  $0  $0  $30,980 

 

5

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

 

1. OPERATIONS

OPERATIONS

 

Genasys Inc. (formerly LRAD® Corporation), a Delaware corporation (the “Company”), is engaged in the design, developmenta global provider of critical communications hardware and commercializationsoftware systems designed to alert, inform, and protect. The Company's unified platform receives information from a wide variety of directedsensors and multidirectional sound technologies, voice broadcast products, location-based mass messaging solutions forInternet-of-Things (IoT) inputs to collect real-time information on developing and active emergency warningsituations. The Company uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise safety,threats, critical events, and evacuation planning and public safety resources. The principal markets for the Company’s proprietary sound reproduction technologies, voice broadcast products mass messaging solutions and public safety resources are in North and South America, Europe, the Middle East and Asia. On October 23, 2019, the Company announced its rebranding and began doing business as Genasys Inc.other crisis situations.

 

 

2. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

 

General

 

The Company’s unaudited interim condensed consolidated financial statements included herein have been prepared in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X and the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In management’s opinion, the accompanying financial statements reflect adjustments necessary to present fairly the financial position, results of operations, and cash flows for those periods indicated, and contain adequate disclosure to make the information presented not misleading. Adjustments included herein are of a normal, recurring nature unless otherwise disclosed in the footnotes. The condensed consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended September 30, 20202021, included in the Company’s Annual Report on Form 10-K, as filed with the SEC on December 10, 2020.November 23, 2021. The accompanying condensed consolidated balance sheet atas of September 30, 20202021 has been derived from the audited consolidated balance sheet atas of September 30, 20202021 contained in the above referenced Form 10-K. Results of operations for interim periods are not necessarily indicative of the results of operations for a full year.

 

Principles of consolidation

 

The Company has 8eight wholly owned subsidiaries, Genasys II Spain, S.A.US.A.U. (“Genasys Spain”), Genasys Communications Canada ULC (“Genasys Canada”), Genasys Singapore PTE Ltd, Genasys Puerto Rico, LLC, Zonehaven LLC, and Genasys Inc. (branch) in the United Arab Emirates and two currently inactive subsidiaries, Genasys America de CV and LRAD International Corporation. The condensed consolidated financial statements include the accounts of these subsidiaries after elimination of intercompany transactions and accounts.

 

Cash, cash equivalents and restricted cash

 

The Company considers all highly liquid investments with an original maturity of three months or less, when purchased, to be cash equivalents. As of June 30, 2022, the amount of cash and cash equivalents was $11,723. As of September 30, 2021, the amount of cash and cash equivalents was $14,540. As of September 30, 2020, the amount of cash and cash equivalents was $23,319.$13,167.

 

The Company considers any amounts pledged as collateral or otherwise restricted for use in current operations to be restricted cash. In addition, the Company excludes from cash and cash equivalents cash required to fund specific future contractual obligations related to business combinations. Restricted cash is classified as a current asset unless amounts are not expected to be released and available for use in operations within one year. As of June 30, 2022, the current portion of restricted cash was $100, and the noncurrent portion was $971. As of September 30, 2021, the current portion of restricted cash was $286$279, and the noncurrent portion was $1,202. As of September 30, 2020, $1,082.the current portion of restricted cash was $282 and the noncurrent portion was $395.

Immaterial correction of prior period financial statements

During the quarter ended December 31, 2020, Company management identified an immaterial error in the previously issued September 30, 2020 consolidated balance sheet. This error resulted in an overstatement of prepaid expenses and accrued liabilities of $5,205 related to a foreign currency forward contract which was presented on a gross basis rather than on a net basis. There was no impact to the consolidated statement of operations or the consolidated statement of cash flows for the year ended September 30, 2020, as a result of this misstatement. Further, there was no impact to the condensed consolidated financial statements as of, and for the nine months ended June 30, 2021, as the forward contract was settled during the first quarter of fiscal 2021.  SEC Staff Accounting Bulletin: No.99 – Materiality and No.108 – Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements were used by management to evaluate the impact of the misstatement. Management concluded that this misstatement had no material impact on either the accompanying condensed consolidated balance sheet as of June 30, 2021, or the previously issued consolidated balance sheet for the year ended September 30, 2020, and therefore the misstatement was corrected in the accompanying condensed consolidated balance sheet for the year ended September 30, 2020. All financial information contained in the accompanying notes to these condensed consolidated financial statements has been revised to reflect the correction of this error.

 

Reclassifications

 

Where necessary, thecertain prior year’s information has been reclassified to conform to the current year presentation.

 

6

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

3. RECENT ACCOUNTING PRONOUNCEMENTS

RECENT ACCOUNTING PRONOUNCEMENTS

 

New pronouncements pending adoption

 

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Measurement of Credit Losses on Financial Instruments, which supersedes current guidance by requiring recognition of credit losses when it is probable that a loss has been incurred. The new standard requires the establishment of an allowance for estimated credit losses on financial assets including trade and other receivables at each reporting date. The new standard will result in earlier recognition of allowances for losses on trade and other receivables and other contractual rights to receive cash. In November 2019, the FASB issued ASU No. 2019-10, Financial Instruments Credit Losses (Topic(ASC 326), Derivatives and Hedging (Topic(ASC 815) and Leases (Topic(ASC 842), which extends the effective date of TopicASC 326 for certain companies until fiscal years beginning after December 15, 2022. The new standard will be effective for the Company in the first quarter of its fiscal year beginning October 1, 2023, and early adoption is permitted. The Company has not completed its review of the impact of this standard on its consolidated financial statements. However, based on the Company’s history of immaterial credit losses from trade receivables, the Company does not expect that the adoption of this standard will have a material effect on the Company’s consolidated financial statements.

 

6

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic(ASC 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting. ASU No. 2020-04 provides optional guidance, expedients and exceptions for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments in this update apply to all entities, subject to meeting the criteria, which participate in contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. ASU No. 2020-04 was subsequently amended by ASU No. 2021-01, Reference Rate Reform (Topic(ASC 848), Scope, which refines the scope of TopicASC 848 and permits optional expedients and exceptions when accounting for derivative contracts and certain hedging relationships. The amendments of these updates are available to all entities as of March 12, 2020 through December 31, 2022. The Company has not yet adopted these amendments.intends to adopt this standard when LIBOR is discontinued. The Company does not expect that the adoption of this standard will have a material effect on the Company’s consolidated financial statements.

 

New pronouncements adopted

In August 2018, the FASB issued ASU No.2018-13,Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which improves fair value disclosure requirements by removing disclosures that are not cost beneficial, clarifying disclosures’ specific requirements and adding relevant disclosure requirements. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The new guidance is effective for all entities for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The Company adopted ASU No.2018-13 on October 1, 2020, with no impact to the condensed consolidated financial statements.

 

4.

BUSINESS COMBINATIONSREVENUE RECOGNITON

 

Zonehaven

On June 7, 2021, the Company completed the acquisition of Zonehaven Inc. (“Zonehaven”) pursuant to the terms of an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, ZH Acquisition I Inc., a Delaware corporation and a wholly-owned subsidiary of the Company, merged with and into Zonehaven, with Zonehaven surviving the merger. Immediately following such merger, ZH Acquisition II LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Company, merged with and into Zonehaven, with ZH Acquisition II LLC, changing its name to Zonehaven LLC and continuing as a wholly-owned subsidiary of the Company and with all the properties, rights, privileges, powers and franchises of Zonehaven vesting in such subsidiary, and all debts, liabilities and duties of Zonehaven, becoming the debts, liabilities and duties of such subsidiary. As a result of the transaction, the Zonehaven business is operated through Zonehaven LLC, a wholly-owned subsidiary of the Company.

Zonehaven provides planning, training, and resources to first responders, public safety agencies, and communities to manage evacuations and repopulations successfully. The Company believes the acquisition of Zonehaven will expand the Company’s enterprise software solutions and enhance the Company’s unified multi-channel critical communications platform.

The Zonehaven acquisition was accounted for as a business combination using the acquisition method pursuant to Accounting Standards Codification (“ASC”) Topic 805. As the acquirer for accounting purposes, the Company has estimated the purchase consideration, assets acquired and liabilities assumed as of the acquisition date, with the excess of the purchase consideration over the fair value of net assets acquired recognized as goodwill. The estimated fair value of assets purchased, and liabilities assumed, in certain cases may be subject to revision based on the final determination of fair value.

7

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

The consideration consisted of the following:

Cash paid (net of cash acquired of $644)

 $11,481 

Common stock issued

  10,938 

Shareholder representative reserve payable

  150 
  $22,569 

The Company funded the cash portion of the total consideration with available cash on hand. The Company also issued 2,165,824 shares of the Company’s common stock to the former owners of Zonehaven. The fair value of the Company’s stock on the closing date was $5.05, resulting in the addition of $10,938 to additional-paid-in-capital. The shareholder representative reserve payable is a current liability and recorded in the current portion of accrued liabilities as of June 30, 2021.

The Company incurred $100 in expenses related to this transaction through June 30, 2021. These expenses were recorded in selling, general and administrative expenses in the condensed consolidated statement of operations as follows: $98 in the third quarter of fiscal 2021 and $2 in the second quarter of fiscal 2021.

Purchase price allocation

Assets acquired

    

Accounts receivable

 $255 

Deferred tax asset

  106 

Intangible assets

  10,100 

Goodwill

  15,403 

Total assets acquired

 $25,864 
     

Liabilities assumed

    

Accounts payable

 $194 

Accrued liabilities

  372 

Deferred tax liability

  2,729 

Total liabilities assumed

  3,295 

Net assets acquired

 $22,569 

The estimated fair value of the identifiable intangible assets acquired and their estimated useful lives are as follows:

  

Fair Value

  

Estimated

Useful Lives

(in years)

 

Developed Technology

 $8,800   7 

Trade Names

  400   5 

Customer Relationships

  900   5 
  $10,100     

Identifiable intangible assets consist of certain technology, trade name and customer relationships purchased from Zonehaven. Identifiable intangible assets are amortized over their estimated useful lives based upon a number of assumptions, including the estimated period of economic benefit and utilization. The weighted average amortization period for identifiable intangible assets acquired is 6.7 years. These intangible assets are classified as Level 3 in the ASC topic 820three-tier fair value hierarchy.

The goodwill for Zonehaven is attributable to combining the Company’s existing emergency communications solutions with the software and software development capabilities of Zonehaven to enhance product offerings. Goodwill is also attributable to the skill level of the acquired workforce. The Company will continue to analyze the transaction and refine its calculations, as appropriate during the measurement period, which could affect the value of goodwill. Goodwill from the Zonehaven acquisition will not be deductible for tax purposes.

Amika Mobile asset purchase

On October 2, 2020, the Company completed the purchase of the assets of Amika Mobile Corporation (“Amika Mobile”) pursuant to an Asset Purchase Agreement. Amika Mobile is a leading provider of integrated emergency and enterprise critical communications based in Ottawa, Canada. The Company believes the Amika Mobile asset purchase will expand the Company’s enterprise software solutions and enhance the Company’s unified multi-channel critical communications platform.

8

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

The Amika Mobile asset purchase was accounted for as a business combination using the acquisition method pursuant to ASC Topic 805. As the acquirer for accounting purposes, the Company has estimated the purchase consideration, assets acquired and liabilities assumed as of the acquisition date, with the excess of the purchase consideration over the fair value of net assets acquired recognized as goodwill.

The consideration consisted of the following:

Cash paid $4,367 
Asset purchase holdback liability  613 
Common stock to be issued  3,431 
  $8,411 

Under the terms of the Asset Purchase Agreement, the Company was required to deposit a holdback liability in the amount of CAD$1,000 into an interest-bearing account as security for potential indemnification claims against the seller. The holdback amount will be released three years from the closing date subject to amounts withheld for actual, pending or potential claims. The Company also agreed to issue 191,267 shares of the Company’s common stock to the seller of the Amika Mobile assets on each of the first, second and third anniversaries of the closing date. The total number of shares of common stock the Company is obligated to issue is 573,801. The fair value of the Company’s common stock on the closing date was $5.98, resulting in an addition of $3,431 to additional paid-in-capital. During the three months ended June 30, 2021, the Company accelerated the issuance of 121,703 of such shares of common stock to a former owner of the Amika Mobile assets. 452,098 shares of the Company’s common stock remain subject to issuance under this obligation. The cash portion of the purchase price was funded from cash on hand.

The Company incurred $264 in expenses related to this transaction through June 30, 2021. These expenses were recorded in selling, general and administrative expenses in the condensed consolidated statement of operations as follows: $22 in the second quarter of fiscal 2021, $10 in the first quarter of fiscal 2021, $132 in the fourth quarter of fiscal 2020 and $100 in the third quarter of fiscal 2020.

Purchase price allocation

Assets acquired

    

Prepaid expenses

 $2 

Fixed assets

  22 

Operating lease right of use asset

  248 

Intangible assets

  2,820 
Goodwill   5,590 

Total assets acquired

 $8,682 
     

Liabilities assumed

    

Accrued liabilities

 $23 

Operating lease liability

  248 

Total liabilities assumed

  271 

Net assets acquired

 $8,411 

The estimated fair value of the identifiable intangible assets acquired and their estimated useful lives are as follows:

  

Fair Value

  

Estimated

Useful Lives

(in years)

 

Developed technology

 $2,500   7 

Customer relationships

  320   7 
  $2,820     

Identifiable intangible assets consist of certain technology and customer relationships purchased from Amika Mobile. Identifiable intangible assets are amortized over their estimated useful lives based upon a number of assumptions, including the estimated period of economic benefit and utilization. The weighted average amortization period for identifiable intangible assets acquired is 7 years. These intangible assets are classified as Level 3 in the ASC topic 820three-tier fair value hierarchy.

9

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

The goodwill for Amika Mobile is attributable to combining the Company’s existing emergency communications solutions with the software and software development capabilities of Amika Mobile to enhance product offerings. Goodwill is also attributable to the skill level of the acquired workforce. Goodwill from the Amika Mobile asset purchase will not be deductible for tax purposes.

5.

REVENUE RECOGNITION

The Company adopted the guidance in Topic 606, onRevenue from Contracts with Customers (“ASC October 1, 2018. 606”The Company adopted the new standard using the full retrospective approach.

Topic 606), outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a five-step analysis in determining when and how revenue is recognized:

 

 

1.

Identify the contract(s) with customers

 

2.

Identify the performance obligations

 

3.

Determine the transaction price

 

4.

Allocate the transaction price to the performance obligations

 

5.

Recognize revenue when the performance obligations have been satisfied

 

TopicASC 606 requires revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services.

 

The Company derives its revenue from the sale of products to customers, contracts, software license fees, other services and freight. The Company sells its products through its direct sales force and through authorized resellers and system integrators. The Company recognizes revenue for goods including software when all the significant risks and rewards have been transferred to the customer, no continuing managerial involvement usually associated with ownership of the goods is retained, no effective control over the goods sold is retained, the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transactions will flow to the Company and the costs incurred or to be incurred in respect of the transaction can be measured reliably. Software license revenue, maintenance and/or software development service fees may be bundled in one arrangement or may be sold separately.

 

Product revenue

 

Product revenue is recognized as a distinct single performance obligation when products are tendered to a carrier for delivery, which represents the point in time that the Company’s customer obtains control of the products. A smaller portion of product revenue is recognized when the customer receives delivery of the products. A portion of products are sold through resellers and system integrators based on firm commitments from an end user, and as a result, resellers and system integrators carry little or no inventory. The Company’s customers do not have a right to return product unless the product is found defective and therefore the Company’s estimate for returns has historically been insignificant

 

Perpetual licensed software

 

The sale and/or license of software products is deemed to have occurred when a customer either has taken possession of, or has the ability to take immediate possession of, the software and the software key. Perpetual software licenses can include one-year maintenance and support services. In addition, the Company sells maintenance services on a stand-alone basis and is therefore capable of determining their fair value. On this basis, the amount of the embedded maintenance is separated from the fee for the perpetual license and is recognized on a straight-line basis over the period to which the maintenance relates.

 

Time-based licensed software

 

The time-based license agreements include the use of a software license for a fixed term, generally one-year, and maintenance and support services during the same period. The Company does not sell time-based licenses without maintenance and support services and therefore revenues for the entire arrangements are recognized on a straight-line basis over the term.

 

Warranty, maintenance and services

 

The Company offers extended warranty, maintenance and other services. Extended warranty and maintenance contracts are offered with terms ranging from one to several years, which provide repair and maintenance services after expiration of the original one-year warranty term. Revenues from separately priced extended warranty and maintenance contracts are recognized based on time elapsed over the service period and classified as contract and other revenues. Revenue from other services such as training or installation is recognized when the service is completed.

 

10
7

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

Multiple element arrangements

 

The Company has entered into a number of multiple element arrangements, such as the sale of a product or perpetual licenses that may include maintenance and support (included in the price of perpetual licenses) and time-based licenses (that include embedded maintenance and support, both of which may be sold with software development services, training, and other product sales). In some cases, the Company delivers software development services bundled with the sale of the software. In multiple element arrangements, the Company uses either the stand-alone selling price or an expected cost plus margin approach to determine the fair value of each element within the arrangement, including software and software-related services such as maintenance and support. In general, elements in such arrangements are also sold on a stand-alone basis and stand-alone selling prices are available.

 

Revenue is allocated to each deliverable based on the relative stand-alone selling pricefair value of each individual element and is recognized when the revenue recognition criteria described above are met, except for time-based licenses which are not unbundled. When software development services are performed and are considered essential to the functionality of the software, the Company recognizes revenue from the software development services on a stage of completion basis, and the revenue from the software when the related development services have been completed.

 

The Company disaggregates revenue by reporting segment (Hardware and Software) and geographically to depict the nature of revenue in a manner consistent with the Company’sits business operations and to be consistent with other communications and public filings. Refer to Note 19,18, Segment Information and Note 20,19, Major Customers, Suppliers and Related Information for additional details of revenues by reporting segment and disaggregation of revenue.

 

Contract assets and liabilities

 

The Company enters into contracts to sell products and provide services and recognizes contract assets and liabilities that arise from these transactions. The Company recognizes revenue and corresponding accounts receivable according to TopicASC 606 and, at times, recognizes revenue in advance of the time when contracts give the Company the right to invoice a customer. Sales commissions are considered incremental and recoverable costs of obtaining a contract with a customer. Subscription related commission costs are deferred and then amortized on a straight-line basis over the period of benefit. The Company may also receive consideration, per terms of a contract, from customers prior to transferring goods to the customer. The Company records customer deposits as a contract liability. Additionally, the Company may receive payments, most typically for service and warranty contracts, at the onset of the contract and before the services have been performed. In such instances, a deferred revenue liability is recorded. The Company recognizes these contract liabilities as revenue after all revenue recognition criteria are met. The table below showsreflects the balancebalances of contract assets and liabilities as of June 30, 2021,2022 and September 30, 2020,2021, including the change between the periods. There were 0 contract assets as of June 30, 2022 and September 30, 2021. The current portion of contract liabilities and the non-currentnoncurrent portion are included in “Accrued liabilities” and “Other liabilities, noncurrent”, respectively, on the accompanying Condensed Consolidated Balance Sheets.condensed consolidated balance sheets. Refer to Note 11,10, Accrued and Other Liabilities for additional details.

 

The Company’s contract liabilities were as follows:

 

 

Customer

deposits

 

Deferred

revenue

 

Total contract

liabilities

  

Customer

deposits

 

Deferred

revenue

 

Total

contract

liabilities

 

Balance at September 30, 2020

 $3,683  $1,024  $4,707 

Balance as of September 30, 2021

 $8,701  $1,428  $10,129 

New performance obligations

 13,821  1,176  14,997  9,701  1,383  11,084 

Recognition of revenue as a result of satisfying performance obligations

 (6,411) (1,124) (7,535) (11,499) (1,461) (12,960)

Effect of exchange rate on deferred revenue

  0  16  16   0  (10) (10)

Balance at June 30, 2021

 $11,093  $1,092  $12,185 

Balance as of June 30, 2022

 $6,903  $1,340  $8,243 

Less: non-current portion

  (1,654) (344) (1,998)  0  (262) (262)

Current portion at June 30, 2021

 $9,439  $748  $10,187 

Current portion as of June 30, 2022

 $6,903  $1,078  $7,981 

 

Remaining performance obligations

 

Remaining performance obligations related to TopicASC 606 represent the aggregate transaction price allocated to performance obligations under an original contract with a term greater than one year, which are fully or partially unsatisfied at the end of the period.

 

8

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

As of June 30, 2021,2022, the aggregate amount of the transaction price allocated to remaining performance obligations was approximately $12,185.$8,243. The Company expects to recognize revenue on approximately $10,187$7,981 or 84%97% of the remaining performance obligations over the next 12 months, and the remainder is expected to be recognized thereafter.

 

11

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

Practical expedients 

 

In cases where the Company is responsible for shipping after the customer has obtained control of the goods, the Company has elected to treat these activities as fulfillment activities rather than as a separate performance obligation. Additionally, the Company has elected to capitalize the cost to obtain a contract only if the period of amortization would be longer than one year. The Company only gives consideration to whether a customer agreement has a financing component if the period of time between transfer of goods and services and customer payment is greater than one year. The Company also utilizes the “as invoiced” practical expedient in certain cases where performance obligations are satisfied over time and the invoiced amount corresponds directly with the value the Company is providing to the customer.

 

 

6.5.

FAIR VALUE MEASUREMENTS

 

The Company’s financial instruments consist principally of cash equivalents, short and long-term marketable securities, accounts receivable, and accounts payable. The fair value of a financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:

 

 

Level 1:

Inputs are based on quoted market prices for identical assets or liabilities in active markets at the measurement date.

 

 

Level 2:

Inputs include quoted prices for similar assets or liabilities in active markets and/or quoted prices for identical or similar assets or liabilities in markets that are not active near the measurement date.

 

 

Level 3:

Inputs include management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument’s valuation.

 

The fair value of the Company’s cash equivalents and marketable securities waswere determined based on Level 1 and Level 2 inputs. The Company didvaluation techniques used to measure the fair value of the “Level not2” have any marketable securities in the Level 3 category as of June 30, 2021 instruments were based on quoted market prices or September 30, 2020. model-driven valuations using significant inputs derived from or corroborated by observable market data. The Company believes that the recorded values of its other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations. The Company did not have any marketable securities in the Level 3 category as of June 30, 2022 or September 30, 2021. There have been no changes in Level 1, Level 2, and Level 3 and no changes in valuation techniques for financial instruments measured at fair value on a recurring basis for the periods ended June 30, 2022 and September 30, 2021.

9

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

Instruments measured at fair value on a recurring basis

 

Cash equivalents and marketable securities: The following tables present the Company’s cash equivalents and marketable securities’ costs, gross unrealized gains and losses, and fair value by major security type recorded as cash equivalents or short-term or long-term marketable securities as of June 30, 2021,2022 and September 30, 2020.2021. Unrealized gains and losses from the remeasurement of marketable securities are recorded in accumulated other comprehensive income (loss) until recognized in earnings upon the sale or maturity of the security.

 

 

June 30, 2021

  

June 30, 2022

 
 

Cost Basis

  

Unrealized

Gain

  

Fair Value

  

Cash

Equivalents

  

Short-term

Securities

  

Long-term

Securities

  

Cost Basis

  

Unrealized

Loss

  

Fair Value

  

Cash

Equivalents

  

Short-term Securities

  

Long-term Securities

 

Level 1:

  

Money Market Funds

 $208  $0  $208  $208  $0  $0 

Money market funds

 $1,184  $0  $1,184  $1,184  $-  $- 
  

Level 2:

  

Certificates of deposit

 1,193  0  1,193  0  469  724  1,025  0  1,025  0  723  302 

Municipal securities

 5,879  2  5,881  0  4,451  1,430  5,413  (56) 5,357  0  3,906  1,451 

Corporate bonds

  1,199   0   1,199   0   1,056   143   917   (25)  892   0   641   251 

Subtotal

  8,271   2   8,273   0   5,976   2,297   7,355   (81)  7,274   0   5,270   2,004 
                          
Total  $8,479  $2  $8,481  $208  $5,976  $2,297  $8,539  $(81) $8,458  $1,184  $5,270  $2,004 

 

12

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)
 
  

September 30, 2020

 
  

Cost Basis

  

Unrealized

Gain

  

Fair Value

  

Cash

Equivalents

  

Short-term

Securities

  

Long-term

Securities

 

Level 1:

                        

Money Market Funds

 $365  $0  $365  $365  $0  $0 
                         

Level 2:

                        

Certificates of deposit

  1,195   0   1,195   0   0   1,195 

Municipal securities

  3,777   4   3,781   0   2,431   1,350 

Corporate bonds

  3,091   3   3,094   0   1,834   1,260 

Subtotal

  8,063   7   8,070   0   4,265   3,805 
                         
Total  $8,428  $7  $8,435  $365  $4,265  $3,805 
  

September 30, 2021

 
  

Cost Basis

  

Unrealized

Gain (Loss)

  

Fair Value

  

Cash

Equivalents

  

Short-term Securities

  

Long-term Securities

 

Level 1:

                        

Money market funds

 $932  $0  $932  $932  $-  $- 
                         

Level 2:

                        

Certificates of deposit

  1,494   0   1,494   0   694   800 

Municipal securities

  5,139   (1)  5,138   0   4,205   933 

Corporate bonds

  928   1   929   0   787   142 

Subtotal

  7,561   0   7,561   0   5,686   1,875 
                         

Total

 $8,493  $0  $8,493  $932  $5,686  $1,875 

 

Instruments measured at fair value on a non-recurring basis

 

Nonfinancial assets: Nonfinancial assets such as goodwill, other intangible assets, long-lived assets held and used, and right-of-use (“ROU”) assets (“ROU assets”) are measured at fair value when there is an indicator of impairment and recorded at fair value only when impairment is recognized or for a business combination. 

 

Goodwill and intangible assets are recognized at fair value during the period in which an acquisition is completed, from updated estimates during the measurement period, or when they are considered to be impaired. These non-recurring fair value measurements, primarily for intangible assets acquired, were based on Level 3 inputs. The Company estimates the fair value of these long-lived assets on a non-recurring basis based on a market valuation approach, engaging independent valuation experts to assist in the determination of fair value.

 

The following table presents nonfinancial assets that were subject to fair value measurement during the nine months ended June 30, 2021.2022. Certain intangible assets, operating lease ROU assets and goodwill are subject to foreign currency translation adjustments. There were no business combinations or indicators of impairment for the nine months ended June 30, 2020.2022.

 

  

Carrying

Value

  

Level 1

  

Level 2

  

Level 3

  

Gain/ (Loss)

 

Goodwill from Zonehaven acquisition

 $15,403  $0  $0  $15,403  $0 

Intangible assets from Zonehaven acquisition

 $9,974  $0  $0  $9,974  $0 

Goodwill from Amika Mobile asset purchase

 $6,001  $0  $0  $6,001  $0 

Intangibles from Amika Mobile asset purchase

 $2,703  $0  $0  $2,703  $0 

Operating lease ROU asset from Amika Mobile asset purchase

 $259  $0  $0  $259  $0 

Foreign currency forward contract: In August 2020, the Company entered into a foreign currency forward contract as an economic hedge against exposure to changes in the Canadian dollar in connection with the Amika Mobile asset purchase. At September 30, 2020, the notional value of the foreign currency forward contract was CAD$6,955 with a maturity date in October 2020. The foreign currency forward contract was classified under Level 2 of the fair value hierarchy. The valuation techniques used to measure the fair value were based on quoted market prices. On October 1, 2020, the foreign currency forward contract was settled for CAD$6,955 (USD$5,281), resulting in a realized loss of $48 on the contract that was recorded in earnings as other income (expense). The foreign currency forward contract liability was recorded in accrued liabilities in the consolidated balance sheet as of September 30, 2020.

  

Carrying

Value

  

Level 1

  

Level 2

  

Level 3

  

Gain/ (Loss)

 

Operating lease ROU asset

 $7  $0  $0   7  $0 

 

1310

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

Holdback Liability: In connection with the Amika Mobile asset purchase, the Company recorded a holdback liability related to potential future adjustments to assets and liabilities, misrepresentations and indemnifications against third-party claims. Adjustments of up to CAD$1,000 (USD$776) will be deducted from the asset purchase holdback liability for up to three years from the closing date. The holdback liability was recorded at the present value which was the fair value at the acquisition date. The Company engaged independent valuation experts to assist in determining the present value of the holdback liability. The expected future payment was discounted using a rate representative of the Company’s payment risk and credit rating. Accretion is recorded in each subsequent reporting period based on the discount factor used to arrive at the original fair value. This change in fair value is recorded in the accompanying condensed consolidated statement of operations. The changes in the carrying amount of the holdback liability is as follows:

Balance as of September 30, 2021

$687 

Accretion

 36 

Currency translation

 (10)

Balance as of June 30, 2022

$713 

 

7.

6. INVENTORIES, NET

INVENTORIES, NET

 

Inventories, net consisted of the following:

 

 

June 30,

 

September 30,

  

June 30,

 

September 30,

 
 

2021

  

2020

  

2022

  

2021

 

Raw materials

 $5,557  $5,220  $7,349  $5,449 

Finished goods

 797  841  795  842 

Work in process

  791   456   1,477   877 

Inventories, gross

 7,145  6,517  9,621  7,168 

Reserve for obsolescence

  (723)  (568)  (815)  (752)

Inventories, net

 $6,422  $5,949  $8,806  $6,416 

 

 

8.

7. PROPERTY AND EQUIPMENT, NET

PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consisted of the following:

 

 

June 30,

 

September 30,

  

June 30,

 

September 30,

 
 

2021

  

2020

  

2022

  

2021

 

Office furniture and equipment

 $1,241  $1,181  $1,252  $1,261 

Machinery and equipment

 1,248  1,184  1,388  1,270 

Leasehold improvements

 2,155  2,056   2,173   2,154 

Construction in progress

  29   8 

Property and equipment, gross

 4,673  4,429  4,813  4,685 

Accumulated depreciation

  (2,837)  (2,499)

Accumulated depreciation and amortization

  (3,169)  (2,930)

Property and equipment, net

 $1,836  $1,930  $1,644  $1,755 

 

Depreciation and amortization expense for property and equipment was $106$101 and $131$106 for the three months ended June 30, 2021,2022 and 2020,2021, respectively. Depreciation expense wasrespectively, and $299 and $306 and $397 for the nine months ended June 30, 2021,2022 and 2020,2021, respectively.

 

 

9.

8. GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS

 

Goodwill is attributable to the acquisitionacquisitions of Genasys Spain and of Zonehaven, and the Amika Mobile asset purchase and is due to combining the integrated emergency critical communications, mass messaging solutions and software development capabilities with existing hardware products for enhanced offerings and the skill level of the acquired workforces. The Company periodically reviews goodwill for impairment in accordance with relevant accounting standards. During

There were no additions to goodwill during the nine months ended June 30, 2022. During the year ended September 30, 2021, the Company added $20,992a total of $21,128 in goodwill related to the Zonehaven acquisition and the Amika Mobile asset purchase. As of June 30, 2022 and September 30, 2021, goodwill was $23,511 and $23,834, respectively. There were 0 impairments to goodwill during the nine months ended June 30, 2021.2022 and 2021, respectively.

The changes in the carrying amount of goodwill by segment for the nine months ended June 30, 2022, were as follows:

  

Hardware

  

Software

  

Total

 

Balance as of September 30, 2021

 $0  $23,834  $23,834 

Currency translation

  0   (323)  (323)

Balance as of June 30, 2022

 $0  $23,511  $23,511 

11

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

Intangible assets and goodwill related to Genasys Spain are translated from Euros to U.S. dollars at the balance sheet date. The net impact of foreign currency exchange differences arising during the period related to goodwill and intangible assets was an increasea decrease of $46.$295. Intangible assets and goodwill related to Amika Mobile are translated from Canadian dollars to U.S. dollars at the balance sheet date. During the nine months ended June 30, 2021, the Company added $13,128 in intangible assets related to the Zonehaven acquisition and the Amika Mobile asset purchase. The net impact of foreign currency exchange differences arising during the nine months ended June 30, 2021, period related to goodwill and intangible assets from the Amika Mobile asset purchase was an increasea decrease of $613.$113.

 

The changes in the carrying amount of goodwillintangible assets by segment for the nine months ended June 30, 2021,2022, arewere as follows:

 

  

Hardware

  

Software

  

Total

 

Balance as of September 30, 2020

 $0  $2,472  $2,472 

Acquisition

  0   20,992   20,992 

Currency translation

  0   444   444 

Balance as of June 30, 2021

 $0  $23,908  $23,908 
  

Hardware

  

Software

  

Total

 

Balance as of September 30, 2021

 $25  $12,779  $12,804 

Amortization

  (3)  (1,618)  (1,621)

Currency translation

  0   (85)  (85)

Balance as of June 30, 2022

 $22  $11,076  $11,098 

 

14

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

The Company’s consolidated intangible assets consisted of the following:

 

 

June 30,

 

September 30,

  

June 30,

 

September 30,

 
 

2021

  

2020

  

2022

  

2021

 

Technology

 $12,148  $655  $11,964  $12,065 

Customer relationships

 1,878  627  1,789  1,855 

Trade name portfolio

 631  228  603  625 

Non-compete agreements

 250  247  220  244 

Patents

  72   72   72   72 
 14,979  1,829  14,648  14,861 

Accumulated amortization

  (1,548)  (886)  (3,550)  (2,057)
 $13,431  $943  $11,098  $12,804 

As of June 30, 2022, future amortization expense is as follows:

Fiscal year ending September 30,

    

2022 (remaining three months)

  535 

2023

  2,112 

2024

  2,099 

2025

  1,983 

2026

  1,849 

Thereafter

  2,520 

Total estimated amortization expense

 $11,098 

 

Amortization expense was $295$537 and $74$295 for the three months ended June 30, 2021,2022 and 2020,2021, respectively. Amortization expense wasrespectively, and $1,621 and $647 and $223 for the nine months ended June 30, 2021,2022 and 2020,2021, respectively.

 

As of

June 30, 2021, 12future amortization expense is as follows:


 

Fiscal year ending September 30,

    

2021 (remaining three months)

 $546 

2022

  2,185 

2023

  2,152 

2024

  2,138 

2025

  2,007 

Thereafter

  4,403 

Total estimated amortization expense

 $13,431 

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

 

10.

9. PREPAID EXPENSES AND OTHER

PREPAID EXPENSES AND OTHER

 

Prepaid expenses and other current assets consisted of the following:

 

 

June 30,

 

September 30,

  

June 30,

 

September 30,

 
 

2021

  

2020

  

2022

  

2021

 

Deposits for inventory

 $528  $54  $68  $997 

Prepaid insurance

 355  264  470  395 

Dues and subscriptions

 255  151  154  213 

Prepaid professional services

 23  158 

Prepaid commissions

 193  82 

Trade shows and travel

 95  103  122  95 

Other

  231   288   203   315 
 $1,464  $860  $1,233  $2,255 

 

Deposits for inventory

 

Deposits for inventory consisted of cash payments to vendors for inventory to be delivered in the future.

 

Prepaid insurance

 

Prepaid insurance consisted of premiums paid for health, commercial and corporate insurance. These premiums are amortized on a straight-line basis over the term of the agreements.

 

Dues and subscriptions

 

Dues and subscriptions consistconsisted of payments made in advance for software subscriptions and trade and professional organizations. These payments are amortized on a straight-line basis over the term of the agreements.

 

Prepaid professional services

Prepaid professional services consisted of payments made in advance for services such as accounting and legal services.

Prepaid commissions

Prepaid commissions represented the current portion of sales commissions paid in connection with obtaining a contract with a customer. These costs are deferred and are amortized on a straight-line basis over the period of benefit, which is typically between three and five years. Amortization of prepaid commissions is included in selling, general and administrative expenses in the accompanying condensed consolidated statement of operations.

Trade shows and travel

 

Trade shows and travel consistsconsisted of payments made in advance for trade show events.

 

1513

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

11.

10. ACCRUED LIABILITIES

ACCRUED AND OTHER LIABILITIES

 

Accrued liabilities consisted of the following:

 

  

June 30,

  

September 30,

 
  

2021

  

2020

 

Payroll and related

 $2,705  $2,545 

Deferred revenue

  748   731 

Customer deposits

  9,439   3,683 

Accrued contract costs

  89   719 

Warranty reserve

  143   126 

Other

  181   76 

Total

 $13,305  $7,880 

  

June 30,

  

September 30,

 
  

2022

  

2021

 

Payroll and related

 $2,756  $3,726 

Deferred revenue

  1,078   1,120 

Customer deposits

  6,903   8,701 

Accrued contract costs

  932   416 

Warranty reserve

  158   146 

Other

  0   2 

Total

 $11,827  $14,111 

 

Other liabilities-noncurrent consisted of the following: 

 

 

June 30,

 

September 30,

  

June 30,

 

September 30,

 
 

2021

  

2020

  

2022

  

2021

 

Deferred extended warranty revenue

 $344  $293  $262  $308 

Customer deposits

 1,654   0 

Deferred tax liabilities

 2,729  0 

Asset purchase holdback liability

  693   0   713   687 

Total

 $5,420  $293  $975  $995 

 

Payroll and related

 

Payroll and related consisted primarily of accrued vacation, bonus, sales commissions and benefits.

 

Deferred revenue

 

Deferred revenue as of June 30, 2021,2022, included prepayments from customers for services, including extended warranty, scheduled to be performed in the twelve months ending June 30, 2022.2023.

 

Customer deposits

 

Customer deposits represent amounts paid by customers as a down payment on hardware orders to be delivered in future periods. The customer deposits classified as noncurrent relate to orders that are expected to be delivered during the fourthtwelve quarter of our fiscal year endedmonths ending September 20, 2022.June 30, 2023.

 

Accrued contract costs

 

Accrued contract costs consistconsisted of accrued expenses for contracting a third-party service provider to fulfill repair and maintenance obligations required under a contract with a foreign military for units sold in the year ended September 30, 2011. Payments to the service provider will be made annually upon completion of each year of service. A new contract was signed with the customer in May 2019 to continue repair and maintenance services through May 2024. These services are being recorded in cost of revenues to correspond with the revenues for these services.

 

Warranty reserve

 

Changes in the warranty reserve and extended warranty were as follows:

 

 

June 30,

 

September 30,

  

June 30,

 

September 30,

 
 

2021

  

2020

  

2022

  

2021

 

Beginning balance

 $126  $150  $146  $126 

Warranty provision

 44  16  38  56 

Warranty settlements

  (27)  (40)  (26)  (36)

Ending balance

 $143  $126  $158  $146 

 

The Company establishes a warranty reserve based on anticipated warranty claims at the time product revenue is recognized. Factors affecting warranty reserve levels include the number of units sold, anticipated cost of warranty repairs and anticipated rates of warranty claims. The Company evaluates the adequacy of the provision for warranty costs each reporting period and adjusts the accrued warranty liability to an amount equal to estimated warranty expense for products currently under warranty.

 

16

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

Deferred extended warranty revenue

 

Deferred extended warranty revenue consistsconsisted of warranties purchased in excess of the Company’s standard warranty. Extended warranties typically range from one to two years.

 

Deferred tax liability

14

 

In connection withGenasys Inc.

Notes to the Zonehaven acquisition, the Company recorded a deferred tax liability related to tax basis differences on acquired intangible assets.Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

Asset purchase holdback liability

 

In connection with the Amika Mobile asset purchase, the Company recorded a holdback liability related to potential future adjustments to assets and liabilities.liabilities, misrepresentations and indemnifications against third-party claims. Adjustments of up to CAD$1,000 (USD$807776) will be deducted from the asset purchase holdback liability for up to three years from the closing date. The liability is recorded at fair value in the condensed consolidated balance sheet.

 

 

12.

11. DEBT

DEBT

 

In connection with the acquisition of Genasys Spain, the Company assumedacquired certain debts of Genasys Spain. The carrying value of the acquired debt approximatesapproximated fair value. The balances of the acquired debt consistconsisted of loans with governmental agencies that were secured with cash collateral. In April 2022, the Ministry of Economy and Competiveness declared the terms of the loan satisfied and the outstanding balance was paid in full using the restricted cash that was pledged as collateral at loan inception as payment of the remaining balance.

The changes in the carrying amount of debt for the nine months ended June 30, 2021. Loans with governmental agencies represent interest free debt granted by ministries within Spain for the purpose of stimulating economic development and promoting research and development. Loans with governmental agencies as of June 30, 2021,2022, are as follows:

 

Agency

Due Date

 

Principal

 

Ministry of Economy and Competitiveness

February 2, 2022

 $18 

Ministry of Economy and Competitiveness

February 2, 2024

  286(a) 
   $304 

(a)

This loan is secured by $286 of cash pledged as collateral by Genasys Spain, which is the current balance of the loan. This amount is included in restricted cash as of June 30, 2021. The Company expects the Ministry of Economy and Competitiveness to declare the terms of the loan satisfied within the next twelve months and that the outstanding balance of the loan will be paid in full during the next twelve months. Accordingly, this has been included in the current portion of notes payable as of June 30, 2021.

The following is a schedule of future annual payments as of June 30, 2021:

2022

 $304 

Total

 $304 

Balance as of September 30, 2021

 $296 

Payments

  (277)

Currency translation

  (19)

Balance as of June 30, 2022

 $0 

 

Revolving line of credit

 

On March 8, 2021, the Company entered into an agreement with MUFG Union Bank, N.A. for a $10 million revolving line of credit. Outstanding balances on the revolving line of credit bear interest at a per annum rate equal to the London Interbank Offered Rate (“LIBOR”) plus 2.25%. The agreement contains a provision for determining an alternative interest rate index in the event the LIBOR rate is no longer available. The agreement contains standard covenants, including affirmative financial covenants, such as the maintenance of a short-term liquidity ratio and a senior leverage ratio, in addition to negative covenants which limit the incurrence of additional indebtedness, loans and equity investments, disposition of assets, mergers and consolidations and other matters customarily restricted in such agreements. The maturity date of this revolving line of credit is March 31, 2023. As of June 30, 2022 and September 30, 2021, there were 0 borrowings on the revolving line of credit. The Company incurred and capitalized $38 of issuance costs related to this revolving line of credit. These issuance costs were recorded in prepaid expenses and other assets in the condensed consolidated balance sheet and have and will be amortized on a straight-line basis over the term of the loan.

 

17

12.


Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

13. LEASES

LEASES

 

The Company determines if an arrangement is a lease at inception. The guidance in ASC Topic 842 defines a lease as a contract, or part of a contract, that conveys the right to control the use of identified property, plant, or equipment (an identified asset) for a period of time in exchange for consideration. Operating Right of Use (“ROU”)lease ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. The Company’s leases do not provide an implicit rate. The Company uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. Additionally, the portfolio approach is used in determining the discount rate used to present value lease payments. The operating ROU asset includes any lease payments made and excludes lease incentives and initial direct costs incurred.

 

The Company entered intois party to operating leases for office and production facilities and equipment under agreements that expire at various dates through 2028. The Company elected the package of practical expedients permitted under the new lease standard. In electing the practical expedient package, the Company is not required to reassess whether an existing or expired contract is or contains a lease, reassess the lease classification for expired or existing leases nor reassess the initial direct costs for leases that commenced before the adoption of TopicASC 842. The Company also elected the short-term lease exemption such that the new lease standard was applied to leases greater than one year in duration. Leases with an initial term of twelve months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term.

 

For leases beginning on or after

October 1, 2019, 15lease components are accounted for separately from non-lease components for all asset classes. Certain of the Company’s leases contain renewal provisions and escalating rental clauses and generally require the Company to pay utilities, insurance, taxes and other operating expenses. The renewal provisions of existing lease agreements were not included in the determination of the operating lease liabilities and the operating ROU assets. Variable payments such as excess usage fees on existing equipment leases were not included in the determination of the lease liabilities and the operating ROU assets as the achievement of the specified target that triggers the variable lease payment is not considered probable. In addition, the Company’s facility lease in Spain has an escalating lease clause based on a consumer price index which is considered a variable lease payment and is not included in the determination of the lease liability and operating ROU asset. A 10% increase in the index would increase the total lease liability approximately $19. The Company’s leases do not contain any residual value guarantees or material restrictive covenants.


 

Upon adoption of Topic 842 as of October 1, 2019, Genasys Inc.

Notes to the Company recognized on its consolidated balance sheet an initial measurement of approximately $7,815 of operating lease liabilities,Condensed Consolidated Financial Statements

(in thousands, except per share and approximately $5,824 of corresponding operating ROU assets, net of tenant improvement allowances. There was no cumulative effect adjustment to retained earnings as a result of the transition to Topic 842. The adoption of Topic 842 did not have a material impact on the Company’s consolidated statement of operations.share amounts)

(Unaudited)

 

During the nine months ended June 30, 2021,2022, the Company added an additional operating lease ROU asset of $259$7 and operating lease liabilitiesliability of $259$7 for office space.equipment. The tables below show the operating lease ROU assets and liabilities as of September 30, 2020,2021, and the balances as of June 30, 2021,2022, including the changes during the periods.

 

  

Operating ROU

assets

 

Operating lease right of use asset at September 30, 2020

 $5,285 

Additional operating lease right of use assets

  259 

Less amortization of operating lease right-of-use assets

  (518)

Effect of exchange rate on operating lease right of use assets

  22 

Operating lease right of use asset at June 30, 2021

 $5,048 
  

Operating lease

ROU assets

 

Operating lease ROU assets as of September 30, 2021

 $4,862 

Additional operating lease ROU asset

  7 

Less amortization of operating lease ROU assets

  (543)

Effect of exchange rate on operating lease ROU assets

  (11)

Operating lease ROU assets as of June 30, 2022

 $4,315 

 

  

Operating lease

liabilities

 

Operating lease liabilities at September 30, 2020

 $7,166 

Additional operating lease liabilities

  259 

Less lease principal payments on operating lease liabilities

  (618)

Effect of exchange rate on operating lease liabilities

  22 

Operating lease liabilities at June 30, 2021

  6,829 

Less non-current portion

  (5,952)

Current portion at June 30, 2021

 $877 
  

Operating lease

liabilities

 

Operating lease liabilities as of September 30, 2021

 $6,608 

Additional operating lease liability

  7 

Less lease principal payments on operating lease liabilities

  (665)

Effect of exchange rate on operating lease liabilities

  (11)

Operating lease liabilities as of June 30, 2022

  5,939 

Less non-current portion

  (5,057)

Current portion as of June 30, 2022

 $882 

 

18

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

As of June 30, 2021,2022, the Company’s operating leases have a weighted-average remaining lease term of 6.866.0 years and a weighted-average discount rate of 4.12%4.14%. The maturities of the operating lease liabilities are as follows:

 

Fiscal year ending September 30,

    

2021 (remaining three months)

 $292 

2022

 1,144 

2022 (remaining three months)

 $289 

2023

 1,091  1,087 

2024

 1,086  1,084 

2025

 1,162  1,058 

2026

 1,071 

Thereafter

  3,104   2,139 

Total undiscounted operating lease payments

 7,879  6,728 

Less imputed interest

  (1,050)  (789)

Present value of operating lease liabilities

 $6,829  $5,939 

 

For the three months ended June 30, 2021,2022 and 2020,2021, total lease expense under operating leases was approximately $246$245 and $228,246, respectively. For each of the nine months ended June 30, 2021,2022 and 2020,2021, total lease expense under operating leases was approximately $735 and $674, respectively. For$735. The Company did not have any short-term lease expense during thethree and nine months ended June 30, 2021,2022 total short-term lease expense was $1 and $3, respectively. There was 0 short-term lease expense during2021.

13.

INCOME TAXES

For thethree and nine months ended June 30, 2020.2022,

14. INCOME TAXES

the Company recorded income tax benefit of $367 reflecting an effective tax rate of 30.07%. For the nine months ended June 30, 2021, the Company recorded income tax expense of $506 reflecting an effective tax rate of 22.48%. ForThe Company expects to utilize its deferred tax asset in the nine months ended June 30, 2020, the Company recorded incomefuture, except for those related to federal R&D tax expense of $742 reflecting an effectivecredit carryforwards and net operating loss carryforwards, R&D credits and foreign tax rate of 22.8%. The Companycredits related to Genasys Spain and Genasys Canada and continues to maintain a partial valuation allowance against its deferred tax assets as the Company believes that the negative evidence that it will be able to recover these net deferred tax assets outweighs the positive evidence.allowance.

 

Accounting Standards Codification TopicASC 740, Accounting for Uncertainty in Income Taxes, requires the Company to recognize in its consolidated financial statements uncertainties in tax positions taken that may not be sustained upon examination by the taxing authorities. If interest or penalties are assessed, the Company would recognize these charges as income tax expense. The Company has not recorded any income tax expense or benefit for uncertain tax positions.

 

 

15.

14. COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

 

Litigation

 

The Company may at times be involved in litigation in the ordinary course of business. The Company will, from time to time, when appropriate in management’sthe Company’s estimation, record adequate reserves in the Company’s consolidated financial statements for pending litigation. Currently, there are no pending material legal proceedings to which the Company is a party or to which any of its property is subject.

16

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

Bonus plan

 

The Company has a bonus plan for employees, in accordance with their terms of employment, whereby they can earn a percentage of their salary based on meeting targeted objectives for orders received, revenue, operating income and operating cash flow. In the nine months ended June 30, 2021,2022, the Company recorded $1,505$1,483 of bonus expense. In the nine months ended June 30, 2020,2021, the Company recorded $1,143$1,505 of bonus expense.

 

Amika Mobile asset purchase

 

In connection with the Amika Mobile asset purchase, the Company recorded a holdback liability related to potential future adjustments to assets and liabilities.liabilities, misrepresentations and indemnifications against third-party claims. Adjustments of up to CAD$1,000 (USD$807776) will be deducted from the asset purchase holdback liability for up to three years from the closing date. The liability is recorded at fair value in the condensed consolidated balance sheet.

 

The Company also agreed to issue 191,267 shares of the Company’s common stock to the sellerformer owners of the Amika Mobile assets on each of the first, second and third anniversaries of the closing date. The total number of shares of common stock the Company is obligated to issue is 573,801. The fair value of the Company’s common stock on the closing date was $5.98, resulting in the addition of $3,431 to additional paid-in-capital. During the three monthsyear ended JuneSeptember 30, 2021, the Company accelerated the issuance of 121,703365,109 of such shares of common stock to a former owner of the Amika Mobile assets. 452,098During the nine months ended June 30, 2022, the Company issued 69,564 shares to the former owners of the Amika Mobile assets. There are 139,128 remaining shares of the Company’s common stock remain subject to issuance under this obligation.

 

19

15.


Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

16. SHARE-BASED COMPENSATION

SHARE-BASED COMPENSATION

 

Stock Option Plansoption plans

 

As of June 30, 2021,2022, the Company had two equity incentive plans. The 2005 Equity Incentive Plan (“2005 Equity Plan”) was terminated with respect to new grants in March 2015 but remains in effect for grants issued prior to that time. The Amended and Restated 2015 Equity Incentive Plan (“2015 Equity Plan”) was adopted by the Company’s Board of Directors on December 6, 2016 and approved by the Company’s stockholders on March 14, 2017. The 2015 Equity Plan was amended by the Company’s Board of Directors on December 8, 2020, to increase the number of shares authorized for issuance from 5,000,000 to 10,000,000. On March 16, 2021, the Company’s stockholders approved athe plan amendment. The 2015 Equity Plan authorizes the issuance of stock options, restricted stock, stock appreciation rights, restricted stock units (“RSUs”) and performance awards, to an aggregate of 10,000,000 new shares of common stock to employees, directors, advisors or consultants. As of June 30, 2021,2022, there were options and restricted stock units outstanding covering 92,50010,000 and 3,015,6373,291,725 shares of common stock under the 2005 Equity Plan and the 2015 Equity Plan, respectively, and 5,143,1654,515,315 shares of common stock available for grant, for a total of 8,251,3027,817,040 shares of common stock currently authorized and unissued under the two equity plans.

 

Share-Based CompensationShare-based compensation

 

The Company’s employee stock options have various restrictions that reduce option value, including vesting provisions and restrictions on transfer and hedging, among others, and are often exercised prior to their contractual maturity.

 

There were 322,000 stock options granted during the nine months ended June 30, 2022. There were 275,000 stock options granted during the nine months ended June 30, 2021.There were 1,133,727 stock options granted during the nine months ended June 30, 2020. The weighted average estimated fair value of employee stock options granted during the nine months ended June 30, 2022 and 2021,was calculated using the Black-Scholes option-pricing model with the following weighted average assumptions (annualized percentages):

 

 

Nine months ended

  

Nine months ended

 
 

June 30,

  

June 30,

 
 

2021

  

2020

  

2022

  

2021

 

Volatility

 48.5% 44.5% 48.2% 48.5%

Risk-free interest rate

 0.6% 1.4% 1.4% 0.6%

Dividend yield

 0.0% 0.0% 0.0% 0.0%

Expected term

 6.6  5.4 

Expected term in years

 6.7  6.6 

 

Expected volatility is based on the historical volatility of the Company’s common stock over the period commensurate with the expected term of the options. The risk-free interest rate is based on rates published by the Federal Reserve Board. The contractual term of the options was seven years. The expected term is based on observed and expected time to post-vesting exercise. The expected forfeiture rate is based on past experience and employee retention data. Forfeitures are estimated at the time of the grant and revised in subsequent periods if actual forfeitures differ from those estimates. Such revision adjustments to expense will be recorded as a cumulative adjustment in the period in which the estimate is changed. The Company has not paid a dividend in fiscal 20212022 and did not pay a dividend in fiscal 2020.2021.

17

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

As of June 30, 2021,2022, there was approximately $787$1,290 of total unrecognized compensation costs related to outstanding employee stock options. This amount is expected to be recognized over a weighted average period of 2.11.4 years. To the extent the forfeiture rate is different from what the Company anticipated, stock-based compensation related to these awards will be different from the Company’s expectations.

 

Performance-Based Stock Options

On August 1, 2016, the Company awarded a performance-basedPerformance-based stock option (PVO) to purchase 750,000 shares of the Company’s common stock to a key executive, with a contractual term of seven years. At the grant date, there were 375,000 performance-based stock options assigned to performance criteria within each of fiscal 2019 and 2020. Vesting is based upon the achievement of certain performance criteria for each of fiscal 2019 and 2020 including a minimum free cash flow margin and net revenue targets. Additionally, vesting is subject to the executive being employed by the Company at the time the Company achieves such financial targets.  

The Company determined that certain performance conditions related to the 2019 and 2020 performance criteria were achieved. 187,500 options related to the 2019 performance criteria vested and 375,000 options related to the 2020 performance criteria vested. The Company recorded a total of $459 in stock-based compensation expense for these options through September 30, 2020, in selling, general and administrative expenses in the consolidated statement of operations.

 

On October 4, 2019, the Company awarded a performance-based stock option (PVO) to purchase 800,000 shares of the Company’s common stock to a key executive, with a contractual term of seven years. Vesting is based upon the achievement of certain performance criteria for each of fiscal 2022 and 2023, including a minimum free cash flow margin and net revenue targets. Additionally, vesting is subject to the executive being employed by the Company at the time the Company achieves such financial targets. Through June 30, 2021, theThe Company has not recorded stock-based compensation expense related to these options.

 

20

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

The Company did not grant any PVO’s during the nine months ended June 30, 2022 and 2021.

 

Restricted Stock Units

During fiscal 2018, the Board of Directors granted 93,330 restricted stock units (“RSUs”) to employees that will vest equally over three years on each of the firstthree anniversary dates of the grant. These were issued at a market value of $210, which will be expensed on a straight-line basis over the three-year life of the grants. 

During fiscal 2019, the Board of Directors granted 99,300 RSUs to employees that will vest equally over three years on each of the firstthree anniversary dates of the grant. These were issued at a market value of $248, which have and will be expensed on a straight-line basis over the three-year life of the grants.

 

On March 10, 2020, each non-employee member of the Board of Directors received a grant of 30,000 RSUs that vested on the first anniversary of the grant date. These were issued at a market value of $425 whichand were expensed on a straight-line basis through the March 10, 2021 vest date. Also, in fiscal 2020, 81,270 RSUs were granted to employees that will vest over three years on the anniversary date of the grant. These were issued at a market value of $258, which have and will be expensed on a straight-line basis over the three-year life of the grants.

 

On March 16, 2021, each non-employee member of the Board of Directors received a grant of 27,883 RSUs that vestedwill vest on the first anniversary of the grant date. These were issued at a market value of $1,100 which have and will bewere expensed on a straight-line basis through the March 16, 2022 vest date. Also, during the fiscal 2021, 145,950 RSUs were granted to employees that will vest over three years on the anniversary date of the grant. These were issued at a market value of $989, which have and will be expensed on a straight-line basis over the three-year life of the grants. During the quarter, On June 7, 2021, 5,000 RSUs with immediate vesting were granted to an employee at a market value of $25. These were expensed during the quarter ended June 30, 2021.On September 1, 2021, two new members of the Board of Directors received a grant of 17,500 RSUs which vested on March 16, 2022. These were issued at a market value of $184 and were expensed on a straight-line basis through the March 16, 2022 vest date.

 

DuringOn March 15, 2022, each non-employee member of the Board of Directors received a grant of 30,000 RSUs that will vest on the first anniversary of the grant date. These were issued at a market value of $407, which have and will be expensed on a straight-line basis through the March 15, 2023 vest date. On November 1, 2021, 10,000 RSUs were granted to a non-employee advisor that will vest on the first anniversary of the grant date. These were issued at a market value of $51, which have and will be expensed on a straight-line basis though the November 1, 2022 vest date. Also, during the nine months ended June 30, 2021,2022, there were 100,800 RSUs granted to employees that will vest over three years on the Company retained 22,073 sharesanniversary of common stock to satisfy tax withholding obligations upon the vestinggrant date. These were issued at a market value of RSUs issued to employees. During$348, which have and will be expensed on a straight-line basis over the ninethree months ended June 30, 2020, -year life of the Company retained 13,063 shares of common stock to satisfy tax withholding obligations upon the vesting of RSUs issued to employees. These shares were not acquired pursuant to any repurchase plan or program.grants.

 

Compensation expense for RSUs was $363$193 and $750$1,216 for the three months and nine months ended June 30, 2021,2022, respectively. Compensation expense for RSUs was $136$363 and $431$750 for the three and nine months ended June 30, 2020,2021, respectively. As of June 30, 2021,2022, there was approximately $1,534$1,204 of total unrecognized compensation costs related to outstanding RSUs. This amount is expected to be recognized over a weighted average period of 1.611.4 years.

A summary of the restricted stock units of the Company as of June 30, 2021, is presented below:

  

Number of

Shares

  

Weighted

Average Grant

Date Fair Value

 

Outstanding September 30, 2020

  303,014  $2.82 

Granted

  290,315  $7.28 

Released

  (228,633) $2.83 

Forfeited/cancelled

  (277) $2.26 

Outstanding June 30, 2021

  364,419  $6.37 

 

2118

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

A summary of the Company’s RSUs as of June 30, 2022 is presented below:

  

Number of

Shares

  

Weighted

Average Grant

Date Fair Value

 

Outstanding September 30, 2021

  399,469  $6.27 

Granted

  260,800  $3.09 

Released

  (270,262) $6.42 

Forfeited/cancelled

  (15,666) $5.15 

Outstanding June 30, 2022

  374,341  $4.00 

Stock Option Summary Informationoption summary information

 

A summary of the activity in options to purchase the capital stock of the Company as of June 30, 2021,2022 is presented below:

 

 

Number of

Shares

  

Weighted

Average

Exercise Price

  

Number of Shares

  

Weighted Average Exercise Price

 

Outstanding September 30, 2020

 2,659,305  $2.56 

Outstanding September 30, 2021

 2,745,384  $3.02 

Granted

 275,000  $6.80  322,000  $4.77 

Forfeited/expired

 (104,125) $2.57  (10,000) $5.43 

Exercised

  (86,462) $1.97   (130,000) $1.95 

Outstanding June 30, 2021

  2,743,718  $3.00 

Exerciseable June 30, 2021

  1,520,058  $2.19 

Outstanding June 30, 2022

  2,927,384  $3.26 

Exerciseable June 30, 2022

  1,589,114  $2.57 

 

Options outstanding are exercisable at prices ranging from $1.31 to $8.03 per share and expire over the period from 20212022 to 20282029 with an average life of 4.073.53 years. The aggregate intrinsic value of options outstanding and exercisable as of June 30, 2021,2022 was $7,150$1,585 and $5,049,$1,584, respectively. The aggregate intrinsic value represents the difference between the Company’s closing stock price on the last day of trading for the quarter, which was $5.48$3.25 per share, and the exercise price multiplied by the number of applicable options. The total intrinsic value of stock options exercised during the nine months ended June 30, 2021,2022 was $455$191 and proceeds from these exercises were $170.was $253. The total intrinsic value of stock options exercised during the nine months ended June 30, 2020,2021 was $1,236$455 and proceeds from these exercises were $996. was $170.

 

The following table summarized information about stock options outstanding as of June 30, 2021:2022:

 

        

Weighted Average

  

Weighted Average

      

Weighted Average

 

Range of

 

Number

  

Remaining

  

Exercise

  

Number

  

Exercise

 

Exercise Prices

 

Outstanding

  

Contractual Life

  

Price

  

Exercisable

  

Price

 
$1.31-

$1.86

  334,991   2.20  $1.64   328,116  $1.64 
$1.99-

$1.99

  937,500   2.69  $1.99   937,500  $1.99 
$2.16-

$3.17

  72,500   0.60  $2.52   72,500  $2.52 
$3.39-

$3.40

  1,133,727   5.34  $3.39   146,005  $3.40 
$5.05-

$8.03

  265,000   6.85  $6.75   35,937  $6.87 
     2,743,718   4.07  $3.00   1,520,058  $2.19 

Range of

Exercise Prices

 

 

Number

Outstanding

  Weighted Average

Remaining

Contractual Term

  Weighted Average

Exercise

Price

  Number

Exercisable

  Weighted Average

Exercise

Price

 

$1.31

-$1.86  259,157   1.53  $1.70   259,157  $1.70 

$1.99

-$1.99  937,500   1.69  $1.99   937,500  $1.99 

$3.21

-$3.21  20,000   6.85  $3.21   0  $0 

$3.39

-$3.39  800,000   4.26  $3.39   0  $0 

$3.43

-$8.03  910,727   5.28  $4.88   392,457  $4.53 
     2,927,384   3.53  $3.26   1,589,114  $2.57 

 

The Company recorded $84$162 and $186$84 of stock option compensation expense for employees, directors and consultants for the three months ended June 30, 2021,2022, and 2020,2021, respectively. The Company recorded $206$434 and $345$206 of stock option compensation expense for employees, directors and consultants for the nine months ended June 30, 2021,2022, and 2020,2021, respectively.

 

19

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

Share-Based CompensationShare-based compensation

 

The Company recorded share-based compensation expense and classified it in the condensed consolidated statements of operations as follows:

 

 Three months ended Nine months ended  

Three Months Ended

 

Nine Months Ended

 
 June 30, June 30,  

June 30,

 

June 30,

 
 2021 2020 2021 2020  

2022

  

2021

  

2022

  

2021

 
Cost of revenues $10  $5  $24  $16  10  $10  53  24 
Selling, general and administrative 424  311  904  738  327  424  1,544  904 
Research and development  12   6   28   22   18   12   53   28 
 $446  $322  $956  $776  $355  $446  $1,650  $956 

 

22

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

16.

17.STOCKHOLDERS EQUITY

 

Summary

 

The following table summarizes changes in the components of stockholders’ equity during the nine months ended June 30, 2021,2022 and the nine months ended June 30, 20202021 (amounts in thousands, except par value and share amounts):

 

                 

Accumulated

                     

Accumulated

    
         

Additional

     

Other

 

Total

  

Common Stock

 

Additional

     

Other

 

Total

 
 

Common Stock

 

Paid-in

 

Accumulated

 

Comprehensive

 

Stockholders'

  

Shares

  

Par Value Amount

  

Paid-in

Capital

  

Accumulated Deficit

  

Comprehensive Loss

  

Stockholders' Equity

 
 

Shares

  

Amount

  

Capital

  

Deficit

  

Loss

  

Equity

 

Balance at September 30, 2020

 33,561,544  $336  $91,248  $(41,858) $(250) $49,140 

Balance as of September 30, 2021

 36,403,833  $364  $107,110  $(41,154) $2  $65,958 

Share-based compensation expense

 -  0  182  0  0  182  -  0  558  0  0  558 

Issuance of common stock upon exercise of stock options, net

 25,899  0  54  0  0  54  15,000  0  46  0  0  46 

Obligation to issue common stock

 -  0  3,431  0  0  3,431 

Accumulated other comprehensive income

 -  0  0  0  469  469 

Stock buyback

 (116,868) (1) (441) 0  0  (441)

Release of obligation to issue commons stock

 69,564  0  0  0  0  0 

Accumulated other comprehensive loss

 -  0  0  0  (85) (85)
Net loss  -   0   0   (619)  0   (619)  -   0   0   (1,305)  0   (1,305)

Balance at December 31, 2020

  33,587,443  $336  $94,915  $(42,477) $219  $52,657 

Balance as of December 31, 2021

  36,371,529  $363  $107,273  $(42,459) $(83) $64,731 
  

Share-based compensation expense

 -  $0  $328  $0  $0  $328  -  0  737  0  0  737 

Issuance of common stock upon exercise of stock options, net

 60,563  1  116  0  0  116  55,000  1  124  0  0  124 

Issuance of common stock upon vesting of restricted stock units

 223,633  2  0  0  0  0  262,342  2  0  0  0  0 

Shares retained for payment of taxes in connection with net share settlement of restricted stock units

 (22,073) 0  (141) 0  0  (141) (18,344) 0  (70) 0  0  (70)

Stock buyback

 (142,442) (1) (557) 0  0  (557)

Accumulated other comprehensive loss

 -  0  0  0  (78) (78) -  0  0  0  (1) (1)

Net income

  -   0   0   262   0   262 

Balance at March 31, 2021

  33,849,566  $339  $95,218  $(42,215) $141  $53,144 

Net loss

  -   0   0   (492)  0   (492)

Balance as of March 31, 2022

  36,528,085  $365  $107,507  $(42,951) $(84) $64,472 
  

Share-based compensation expense

 -  $0  $446  $0  $0  $446  -  0  355  0  0  355 

Issuance of common stock upon exercise of stock options, net

 60,000  1  83  0  0  83 

Issuance of common stock upon vesting of restricted stock units

 5,000  0  0  0  0  0  7,920  0  0  0  0  0 

Issuance of common stock in business combination

 2,165,824  22  10,938  0  0  10,938 

Release of obligation to issue commons stock

 121,703  1  0  0  0  0 

Accumulated other comprehensive income

 -  0  0  0  183  183 

Net income

  -   0   0   290   0   290 

Balance at June 30, 2021

  36,142,093  $362  $106,602  $(41,925) $324  $65,001 

Accumulated other comprehensive loss

   0  0  0  (452) (452)

Net loss

      0   0   (589)  0   (589)

Balance as of June 30, 2022

  36,596,005  $366  $107,945  $(43,540) $(536) $63,869 

 

2320

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 
                  

Accumulated

     
          

Additional

      

Other

  

Total

 
  

Common Stock

  

Paid-in

  

Accumulated

  

Comprehensive

  

Stockholders'

 
  

Shares

  

Amount

  

Capital

  

Deficit

  

Loss

  

Equity

 

Balance at September 30, 2019

  32,949,987  $330  $89,572  $(53,732) $(459) $35,381 

Share-based compensation expense

  -   0   158   0   0   158 

Issuance of common stock upon exercise of stock options, net

  83,343   1   144   0   0   144 

Accumulated other comprehensive income

  -   0   0   0   85   85 

Net income

  -   0   0   620   0   620 

Balance at December 31, 2019

  33,033,330  $331  $89,874  $(53,112) $(374) $36,388 
                         

Share-based compensation expense

  -   0   296   0   0   296 

Issuance of common stock upon exercise of stock options, net

  56,861   0   114   0   0   114 

Issuance of common stock upon vesting of restricted stock units

  198,106   0   0   0   0   0 

Shares retained for payment of taxes in connection with net share settlement of restricted stock units

  (13,063)  0   (41)  0   0   (41)

Stock buyback

  (156,505)  0   (398)  0   0   (398)

Accumulated other comprehensive loss

  -   0   0   0   (69)  (69)
Net loss  -   0   0   302   0   302 

Balance at March 31, 2020

  33,118,729  $331  $89,845  $(52,810) $(443) $36,592 
                         

Share-based compensation expense

  -   0   322   0   0   322 

Issuance of common stock upon exercise of stock options, net

  371,815   4   738   0   0   738 

Accumulated other comprehensive income

  -   0   0       51   51 
Net income  -   0   0   1,504   0   1,504 

Balance at June 30, 2020

  33,490,544  $335  $90,905  $(51,306) $(392) $39,207 

                  

Accumulated

     
  

Common Stock

  

Additional

      

Other

  

Total

 
  

Shares

  

Par Value

Amount

  

Paid-in

Capital

  

Accumulated Deficit

  

Comprehensive Loss

  

Stockholders' Equity

 

Balance as of September 30, 2020

  33,561,544  $336  $91,248  $(41,858) $(250) $49,140 

Share-based compensation expense

  -   0   182   0   0   182 

Issuance of common stock upon exercise of stock options, net

  25,899   0   54   0   0   54 

Obligation to issue common stock

  -   0   3,431   0   0   3,431 

Accumulated other comprehensive income

  -   0   0   0   469   469 

Net loss

  -   0   0   (619)  0   (619)

Balance as of December 31, 2020

  33,587,443  $336  $94,915  $(42,477) $219  $52,657 
                         

Share-based compensation expense

  -  $0  $328  $0  $0  $328 

Issuance of common stock upon exercise of stock options, net

  60,563   1   116   0   0   116 

Issuance of common stock upon vesting of restricted stock units

  223,633   2   0   0   0   0 

Shares retained for payment of taxes in connection with net share settlement of restricted stock units

  (22,073)  0   (141)  0   0   (141)

Accumulated other comprehensive loss

  -   0   0   0   (78)  (78)

Net income

  -   0   0   262   0   262 

Balance at March 31, 2021

  33,849,566  $339  $95,218  $(42,215) $141  $53,144 
                         

Share-based compensation expense

  -  $0  $446  $0  $0  $446 

Issuance of common stock upon vesting of restricted stock units

  5,000   0   0   0   0   0 

Issuance of common stock in business combination

  2,165,824   22   10,938   0   0   10,938 

Release of obligation to issue commons stock

  121,703   1   0   0   0   0 

Accumulated other comprehensive income

  -   0   0   0   183   183 

Net income

  -   0   0   290   0   290 

Balance at June 30, 2021

  36,142,093  $362  $106,602  $(41,925) $324  $65,001 

 

Common stock activity

 

OnDuring the March 18, 2021,nine months ended June 30, 2022, the Company filed an amendment to its Certificate of Incorporation, as amended, with the Secretary of State of Delaware to increase the authorized number ofissued 130,000 shares of common stock and received gross proceeds of $253 in connection with the exercise of stock options and the Company from 50,000,000 to 100,000,000issued 251,918 shares (the “Amended Certificate”). The Amended Certificate was approved byof common stock in connection with the Company’s stockholders at the Company’s Annual Meetingvesting of Stockholders on March 16, 2021.

RSUs. During the nine months ended June 30, 2021, the Company issued 86,462 shares of common stock and received gross proceeds of $170 in connection with the exercise of stock options. During the nine months ended June 30, 2020, the Company issued 512,019 shares of common stockoptions and received gross proceeds of $996 in connection with the exercise of stock options. During the nine months ended June 30, 2021, the Company issued 206,560 shares of commoncommons stock in connection with the vesting of RSUs. During the nine months ended June 30, 2020, the Company issued 185,043 shares of common stock in connection with the vesting of RSUs. 

 

In connection with the Amika Mobile asset purchase, the Company agreed to issue 191,267 shares of the Company’s common stock to the former ownerowners of the Amika Mobile assets on each of the first, second and third anniversaries of the closing date. The total number of shares of common stock the Company is obligated to issue is 573,801. The fair value of the Company’s common stock on the closing date was $5.98, resulting in the addition of $3,431 to additional paid-in-capital. During the three monthsyear ended JuneSeptember 30, 2021, the Company accelerated the issuance of 121,703365,109 of such shares of common stock to a former owner of the Amika Mobile. 452,098Mobile assets. During the nine months ended June 30, 2022, the Company issued 69,564 shares to the former owners of the Amika Mobile assets. There are 139,128 remaining shares of the Company’s common stock remain subject to issuance under this obligation.

In connection with the Zonehaven acquisition, the Company issued 2,165,824 shares of the Company’s common stock to the former owners of Zonehaven. The fair value of the Company’s stock on the closing date was $5.05, resulting in the addition of $10,938 to additional-paid-in-capital.

 

Share buyback program

 

In December 2018, the Board of Directors approved a new share buyback program beginning January 1, 2019 and expiring on December 31, 2020, under which the Company was authorized to repurchase up to $5 million of its outstanding common shares. In December 2020, the Board of Directors extended the buyback program until December 31, 2022. The previous program expired on December 31, 2018.

 

During the nine months ended June 30, 2021,2022, 0259,310 shares were repurchased by the Company. Duringfor $998. There were 0 shares repurchased during the nine months ended June 30, 2020,2021. the CompanyAs of June 30, 2022, all repurchased 156,505 shares for $398.were retired.

 

24

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

Dividends

 

There were 0 dividends declared in the nine months ended June 30, 20212022 and 2020.2021.

21

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

 

18.

17. NET INCOME (LOSS) PER SHARE

NET (LOSS) INCOME PER SHARE

 

The following table sets forth the computation of basic and diluted net (loss) income per share:

 

 

Three months ended

 

Nine months ended

  

Three months ended

 

Nine months ended

 
 

June 30,

  

June 30,

  

June 30,

  

June 30,

 
 

2021

  

2020

  

2021

  

2020

  

2022

  

2021

  

2022

  

2021

 

Net income (loss)

 $290  $1,504  $(67) $2,426 

Net (loss) income

 $(589) $290  $(2,386) $(67)
  

Basic income (loss) per share

 $0.01  $0.05  $(0.00) $0.07 

Diluted income (loss) per share

 $0.01  $0.04  $(0.00) $0.07 

Basic (loss) income per share

 $(0.02) $0.01  $(0.07) $(0.00)

Diluted (loss) income per share

 $(0.02) $0.01  $(0.07) $(0.00)
  

Weighted average shares outstanding - basic

 34,109,167  33,289,426  33,797,774  33,122,042  36,566,900  34,109,167  36,459,179  33,797,774 

Assumed exercise of dilutive options

  1,161,778   991,489   0   756,201   0   1,161,778   0   0 

Weighted average shares outstanding - diluted

  35,270,945   34,280,915   33,797,774   33,878,243   36,566,900   35,270,945   36,459,179   33,797,774 
  

Potentially diluted securities outstanding at period end excluded from diluted computation as the inclusion would have been antidilutive:

 

Potentially dilutive securities outstanding at period end excluded from diluted computation as the inclusion would have been antidilutive:

 

Options

 1,035,000  893,750  2,743,718  893,750  2,927,384  1,035,000  2,927,384  2,743,718 

RSU

 0  0  364,469  0  374,341  0  374,341  364,469 

Obligation to issue common stock

  452,098   0   452,098   0   139,128   452,098   139,128   452,098 

Total

  1,487,098   893,750   3,560,285   893,750   3,440,853   1,487,098   3,440,853   3,560,285 

 

 

19.

18. SEGMENT INFORMATION

SEGMENT INFORMATION

 

The Company is engaged in the design, development and commercialization of directed and multidirectional sound technologies, voice broadcast products, and location-based mass messaging solutionssoftware for emergency warning and enterprise safety, and evacuation planning and public safety resources.management. The Company operates in 2 business segments: Hardware and Software and its principal markets are North and South America, Europe, the Middle East and Asia. As reviewed by the Company’s chief operating decision maker, the Company evaluates the performance of each segment based on sales and operating income. Cash and cash equivalents, marketable securities, accounts receivable, inventory, property and equipment, deferred tax assets, goodwill and intangible assets are primary assets identified by segment. The accounting policies for segment reporting are the same for the Company as a whole.

 

2522

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

The following table presents the Company’s segment disclosures:

 

 

Three months ended June 30,

 

Nine months ended June 30,

  

June 30,

 

June 30,

 
 

2021

  

2020

  

2021

  

2020

  

2022

  

2021

  

2022

  

2021

 
  

Revenue from external customers

  

Hardware

 $11,875  $11,599  $29,887  $27,820  $13,419  $11,877  $36,041  $29,889 

Software

  752   372   2,069   1,209   733   750   1,956   2,067 
 $12,627  $11,971  $31,956  $29,029  $14,152  $12,627  $37,997  $31,956 
  

Intersegment revenues

  

Hardware

 $0  $0  $0  $0  $0  $0  $0  $0 

Software

  581   552   1,187   1,381   860   581   2,354   1,187 
 $581  $552  $1,187  $1,381  $860  $581  $2,354  $1,187 
  

Segment operating income (loss)

  

Hardware

 $1,671  $2,144  $3,420  $3,525  $2,495  $1,938  $6,204  $4,242 

Software

  (1,151)  (203)  (3,040)  (559)  (3,124)  (1,418)  (8,969)  (3,862)
 $520  $1,941  $380  $2,966  $(629) $520  $(2,765) $380 
  

Other expenses:

  

Depreciation and amortization expense

  

Hardware

 $98  $127  $282  $387  $95  $98  $285  $282 

Software

  303   78   671   233   543   303   1,635   671 
 $401  $205  $953  $620  $638  $401  $1,920  $953 
  

Income tax expense

 

Income tax expense (benefit)

 

Hardware

 $228  $473  $506  $742  $(13) $447  $1,053  $978 

Software

  0   0   0   0   (18)  (219)  (1,420)  (472)
 $228  $473  $506  $742  $(31) $228  $(367) $506 

 

 

June 30,

 

September 30,

 
 

June 30, 2021

  

September 30, 2020

  

2022

  

2021

 

Long-lived assets

  

Hardware

 $1,826  $1,924  $1,623  $1,748 

Software

  37,349   3,421   11,119   12,811 
 $39,175  $5,345  $12,742  $14,559 
  

Total assets

  

Hardware

 $53,232  $61,152  $47,177  $50,364 

Software

  40,335   5,015   37,934   39,764 
 $93,567  $66,167  $85,111  $90,128 

 

 

19.

MAJOR CUSTOMERS, SUPPLIERS AND RELATED INFORMATION

For the 20.three MAJOR CUSTOMERS, SUPPLIERS AND RELATED INFORMATIONmonths ended June 30, 2022, revenues from one customer accounted for 77% of total revenues with no other single customer accounting for more than 10% of revenues. For the nine months ended June 30, 2022, revenues from one customer accounted for 70% of total revenues with no other single customer accounting for more than 10% of revenues. As of June 30, 2022, accounts receivable from two customers accounted for 61% and 19% of total accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance.

 

For the three months ended June 30, 2021, revenues from 1one customer accounted for 62% of total revenues with no other single customer accounting for more than 10% of revenues. For the nine months ended June 30, 2021, revenues from 1one customer accounted for 54% of total revenues with no other single customer accounting for more than 10% of revenues. As of June 30, 2021, accounts receivable from 2two customers accounted for 51% and 17% of total accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance.

 

For the three months ended June 30, 2020, revenues from 1 customer accounted for 64% of total revenues with no other single customer accounting for more than 10% of revenues. For the nine months ended June 30, 2020, revenues from 1 customer accounted for 63% of total revenues with no other single customer accounting for more than 10% of revenues. As of June 30, 2020, accounts receivable from 2 customers accounted for 60% and 17% of total accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance.

2623

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

Revenue from customers in the United States was $10,564$12,631 and $9,600$10,564 for the three months ended June 30, 2021,2022 and 2020,2021, respectively. Revenue from customers in the United States was $24,401$31,465 and $22,523$24,401 for the nine months ended June 30, 2021,2022 and 2020,2021, respectively. The following table summarizes revenues by geographic region. Revenues are attributed to countries based on customer’s delivery location. The following table summarizes revenues by geographic region.

 

 

Three months ended June 30,

 

Nine months ended June 30,

  

June 30,

 

June 30,

 
 

2021

  

2020

  

2021

  

2020

  

2022

  

2021

  

2022

  

2021

 

Americas

 $11,090  $9,961  $25,496  $23,871  $12,674  $11,090  $32,205  $25,496 

Asia Pacific

 887  948  4,110  3,129  514  887  2,969  4,110 

Europe, Middle East and Africa

  650   1,062   2,350   2,029   964   650   2,823   2,350 

Total Revenues

 $12,627  $11,971  $31,956  $29,029  $14,152  $12,627  $37,997  $31,956 

The following table summarizes long-lived assets by geographic region.

  

June 30,

  

September 30,

 
  

2022

  

2021

 

United States

  10,079  $11,342 

Americas (excluding the United States)

  2,204   2,542 

Europe, Middle East and Africa

  459   675 

Total long lived assets

 $12,742  $14,559 

 

2724

 
 

Item 2.          Managements Discussion and Analysis of Financial Condition and Results of Operations

 

The discussion and analysis set forth below should be read in conjunction with the accompanying unaudited condensed consolidated financial statements and the related notes included under Item 1 of this Quarterly Report on Form 10-Q, together with Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended September 30, 2020.2021.

 

Forward Looking Statements

 

This report contains certain statements of a forward-looking nature relating to future events or future performance. Words such as expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements but are not the only means of identifying forward-looking statements. Prospective investors are cautioned that such statements are only predictions -and actual events or results may differ materially. In evaluating such statements, prospective investors should specifically consider various factors identified in this report and any matters set forth under Part I, Item 1A (Risk Factors) of our Annual Report on Form 10-K, which could cause actual results to differ materially from those indicated by such forward-looking statements.

 

For purposes of this Quarterly Report, the terms we,us,ourGenasys and the Company refer to Genasys Inc. and its consolidated subsidiaries.

Overview

Genasys Inc. is a global provider of critical communications hardware and software solutionssystems designed to alert and inform to help keep people safe. Our unified platform encompassesreceives information from a multi-channel approachwide variety of sensors and Internet-of-Things (IoT) inputs to delivercollect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions and informationthrough multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations.

 

Our multi-channel approach includes:

 

Genasys Emergency Management (GEM) is Genasys’ software-based product platform. The GEM product line consists of GEM Software, IMNS, and Zonehaven.

LRADGEM Software ® (Long Range Acoustic Device®), the world’s leading Acoustic Hailing Device (“AHD”), projects alert tonesis an interactive, cloud-based SaaS solution that sends critical information to at-risk individuals or groups when an emergency occurs. GEM Software acts as both a communications input and audibleoutput, receiving information from state-of-the-art sensors and emergency services, and quickly relaying notifications, alerts, and instructions to at-risk populations and first responders. GEM Software operators can create and send critical, verified, and secure notifications and messages using emails, voice calls, text messages, with exceptional vocal clarity in a 30° beam from close range to 5,500 meters.panic buttons, desktop alerts, television, social media, and more.

 

GEMIntegrated Mass Notification System (IMNS) (Genasys Emergency Management) is our unified software platform for cloud, on-premiseGenasys’ comprehensive GEM Software and Genasys hardware emergency response solution. IMNS gives operators the ability to communicate critical notifications across platforms using a command and control interface that can be accessed from an emergency operations center, authorized computer, or hybrid operations that supports 2-way communications and seamlessly integrates with physical systems to initiate life-safety actions in defined geographic areas. GEM receives and manages simultaneous inputs from panic buttons, government agency or weather alert feeds, sensor events from digital thermometers, access control, fire panels, camera systems, and more. Using the information derived from the inputs, GEM delivers alertssmart phone. Alerts and notifications on multiple channels, including SMS, CBC, MMS,can be sent via text messages, emails, IPAWS, desktop laptop, tablet and smartphone pop-ups,alerts, television, voice calls, social media, VoIP, callouts, public address, overhead displays, digital signs, tickers, RSS feeds, and email on any platform.Genasys speaker systems. IMNS creates layered redundancy that enables the maximum number of people to receive critical communications.

 

IMNS (Integrated Mass Notification Systems) Zonehavenspan multiple hardware is a multi-faceted SaaS solution that serves both first responders and the communities they protect. Zonehaven can function as a standalone application or as a GEM software notification channels to reachintegration. When an incident occurs, the Zonehaven platform maps and simulates the speed and direction of the incident and determines which zones (geographic areas) are at risk individuals and populations. These systems include Genasys voice speaker arrays, which project sirensneed to be evacuated. As an incident develops, Zonehaven’s real-time incident, evacuation status, and audible voice messages 60° - 360° with industry-leading vocal clarity from close rangerepopulation updates provide emergency agencies and at-risk people current information to more than 14 square kilometers, and GEM software designed to deliver SMS, CBC, text, email, and social media alerts to people at risk in defined geographic areas. Our IMNS solutions are compatible with the Federal Emergency Management Agency (“FEMA”) Integrated Public Alert & Warning System (“IPAWS”) and other major emergency warning protocols.help them stay safe.

 

National Emergency Warning System (NEWS) software provides multi-channel public safety notifications and instructions to designated areas, groups, or agencies when a crisis occurs. The NEWS platform is cloud-based, geo-redundant, and end-to-end encrypted. When implemented with mobile telecom services, NEWS delivers Location-based SMS and Cell Broadcast alerts and notifications to anyone, anywhere, with no recipient opt-in, registration, or download required. While other SMS alert providers take up to 15 minutes to find the mobile phones of people in at-risk areas, NEWS locates recipients and delivers messages in near real time. NEWS’ data is anonymized to help people stay safe and informed without sacrificing privacy.

NEWS (National Emergency Warning Systems) are deployed directly on mobile carrier networks to send critical alerts and life-saving information across SMS and CBC channels to anyone, anywhere with no opt-in required. NEWS empowers national emergency management personnel to send hyper-specific instructions to at risk populations and monitor evacuation progress.

LRAD is the world’s leading Acoustic Hailing Device (AHD). LRAD systems broadcast siren tones and audible voice messages with exceptional vocal clarity from close range to 5,500 meters. LRAD systems are used throughout the world in multiple applications to safely hail and warn, inform and direct, prevent misunderstandings, determine intent, establish large safety zones, resolve uncertain situations, and save lives.

25

 

Zonehavenis a cloud-based, software platform that usesOur critical data and modeling capabilities to deliver simple, usable insights to help emergency responders, communities, counties, and states plan for and successfully respond to All Hazards emergency situations

The Company’s critical communicationcommunications systems are being used in more than 100 countries throughout the world in a range of diverse applications includingthat include public safety, emergency warning, mass notification, defense, law enforcement, border and homeland security, critical event management,infrastructure protection, and many more. We continue to develop new communicationcritical ommunications innovations and believe we have established significant competitive advantages in our principal markets.

LRAD systems represent a technological breakthrough in broadcasting audible, highly intelligible voice messages and tones over long distances and high ambient noise using minimal power. By broadcasting audible voice messages with exceptional vocal clarity and only where needed, we offer novel sound applications that conventional bullhorns, loudspeakers, public address, and emergency warning systems cannot achieve. Our LRAD systems are designed to enable users to safely hail and warn, inform and direct, prevent misunderstandings, determine intent, establish large safety zones, resolve uncertain situations, and save lives. The LRAD product line offers a full range of AHD and communication solutions - from portable devices to permanently installed, remotely operated systems. We continue to expand into new markets and add new models and features to meet customer requirements.

28

Building on the success of our LRAD systems, we designed and developed our multidirectional Genasys mass notification product line. Unlike siren-only installations, our public safety mass notification hardware systems broadcast both emergency warning sirens and highly intelligible voice messages with uniform 60° - 360° coverage over local and wide areas. We believe our ability to shape the broadcast coverage area, our industry-leading speech intelligibility, and our multiple system activation and control options enable us to successfully compete in the large and growing mass notification market.

GEM is our cloud, on-premise or hybrid based software notification platform that enables emergency personnel, first responders, municipalities, companies, educational institutions, and government agencies to send public safety warnings and notifications to the mobile devices and desktop computers of individuals or populations in specific geographic areas with reliability, speed and ease. Alerts and notifications can be sent from a desktop or our mobile application.

NEWS’ location-based SMS software technology sends geo-specific alerts to mobile phones in crisis-affected areas. With no opt in or app download required, NEWS provides the industry’s fastest location-based SMS alert service available, finding and sending SMS public safety alerts and notifications to thousands of mobile phones in near real time.

Zonehaven reduces evacuation and response times for communities, counties, and regions during disasters and other crisis situations. The zone-based evacuation plans include population locations, structures, and traffic flow, and local knowledge of past emergencies and known local hazards. Zonehaven provides a single access point for public safety agencies to gather data and disseminate critical information, evacuation routes, and incident status

Genasys offers the only unified critical communications platform that provides multi-modal, geo-targeted mobile device alerts, and speaker arrays that broadcast audible messages with industry-leading vocal clarity and area coverage. Our user-friendly software interface and mobile application manages and delivers notifications and information to people at risk, before, during, and after crisis situations.

 

Business developments in the fiscal quarter ended June 30, 2021:2022:

 

Acquired Zonehaven, an emergency evacuation planning and public safety resources software provider

Received $15.7 million LRAD order from the U.S. Army under AHD Program of Record

 

Received $28.0 million in follow-on AHD program of record orders from the U.S. Army

Announced GEM government and enterprise software contracts and expanded GEM and Zonehaven software services in multiple cities, counties and states

 

Announced $9.0 million U.S. Army mobile mass notification systems order

Awarded $1.5 million in LRAD foreign military sales and defense orders

 

Awarded mass notification and emergency management software services contract from Riverside County, CA

Announced next generation IMNS installations in Japan and order from U.S. Army

 

Received $3.0 million in LRAD domestic and international security orders

• Announced $1.0 million in international infrastructure protection and wildlife preservation orders

• Received IMNS order from Southern Marin Fire Protection District

Shipped and received new orders for the LRAD 950NXT, the Company's next generation remotely operated long-range communication system

 

Revenues infor the Company’s third quarter of fiscal quarter ended June 30, 2021,2022, were $12.6$14.2 million, an increase from $11.9$12.6 million in the third fiscal quarter of 2020. The increase in revenues was driven by increases of AHD, IMNS and software revenues. AHD revenue was $11,420, an increase of $961 or 9%,fiscal 2021. IMNS revenue was $455, a decrease($3.9 million) increased $3,437, offset by decreases of $685 or 60%, and$17 in software revenue of $752, an increase of $380 or 102%,($733) and $1,895 in LRAD revenue ($9.5 million) compared with the third fiscal quarter of 2020. Based on theprior year quarter. The timing of government budget cycles, government financial issues the impact of the COVID-19 pandemic and leadership changemilitary conflict in certain areas of the world, delays in awarding contracts often occur,delay contract awards, resulting in uneven quarterly revenues.revenue. Gross profit increased compared withto the same quarter in the prior year primarily as a result of higher sales. Operating expenses increased 36% from the prior year quarter, from $4.5 million to $6.2 million in the quarter ended June 30, 2021. Third fiscal quarter of 2021 results reflect $228 of income tax expense,2022, increased 22.2% to $7.2 million, compared with $473$5.9 million in the same period in the prior year quarter.year. We reported a net incomeloss of $290$589 for the third quarter of fiscal 2022, or $0.01a loss of $0.2 per share, compared with net income of $1,504,$290, or $0.05$0.01 per share, for the same quarter in the prior year.

 

29

Overall Business Outlook

 

Our product line-up continuesproducts, systems and solutions continue to gain worldwide awareness and recognition through media exposure, product demonstrations, and word of mouth as a result of positive responses and increased acceptance of our products.acceptance. We believe we have a solid global brand, technology and product foundation, with our LRAD systems and IMNS solutions, which we have expanded over the yearscontinue to expand to serve new markets and customers for greater business growth.  We believe that we have strong market opportunities for our product offerings throughout the world in the defense, public safety, emergency warning, mass notification, law enforcement, and border and homeland security and defense sectors as a result of increasing threats to government, commerce, law enforcement, borders,homeland security, and critical infrastructure. Our directionalproducts, systems and multidirectional product offeringssolutions also have many applications within the fire rescue, public safety, maritime, asset protection, and wildlife preservation business segments.

 

The proliferation of natural disasters, crisis situations, and civil unrest require technologically advanced, multi-channel solutions to deliver clear and timely critical communications to help keep the public safe during emergencies. Businesses are also incorporating communication systems that locate and help safeguard employees when critical events occur.

By providing the only unified platform that combines audible, highly intelligible voice broadcast systems and mass messaging software, Genasys seeks to deliver reliable, fast, and intuitive solutions for sending location-based audible voice communications and geolocation-targeted messages and texts to mobile devices to help keep the public and workers safe.

Genasys has developed a global market and an increased demand for LRAD systems and advanced emergency warningoutdoor mass notification solutions.speakers. We have a reputation for producing quality products that feature industry-leadingindustry leading broadcast area coverage, vocal intelligibility, and geo-targeted mass messaging. While the mass notification market is more mature with many established manufacturers and suppliers, we believe that our advanced technology and unified multi-channel platform provides opportunities to succeed in the large and growing public safety, emergency warning, and mass notification markets.product reliability. We also plan to expand and strengthen domestic and international sales by adding strategic mass notification partners, distributors, and dealers.

We planintend to continue building on our AHD leadership position by offering enhanced voice broadcast and multidirectional voice broadcast systems and accessories for an expanding range of applications. In executing our strategy, we use direct sales to governments, militaries, large end-users, system integrators, and system integrators.prime vendors. We have built a worldwide distribution channel consisting of partners and resellers that have significant expertise and experience selling integrated communication solutions into our various target markets. As our primary AHD sales opportunities are with domestic and international government,governments, military branches, and law enforcement agencies, we are subject to each customer’s unique budget cycle, which leads to long selling cycles and uneven revenue flow, complicating our product planning. 

 

The proliferation of natural and man-made disasters, emergency events, violent civil unrest and military conflicts require technologically advanced, multi-channel solutions to deliver clear and timely critical communications to help keep people safe during crisis situations. Businesses are also implementing critical communication and emergency management systems that locate and help safeguard employees when crises occur.

By providing the only SaaS platform that unifies sensors and IoT inputs with multi-channel, multi-agency alerting and notifications, Genasys seeks to deliver reliable, fast, and intuitive solutions for creating and disseminating geolocation-targeted warnings, information, and instructions before, during, and after public safety and business threats, critical events, and other life-safety situations.

26

While the mass notification market is more mature with many established manufacturers and suppliers, we believe that our advanced technology and unified platform provides opportunities to succeed in the large and growing public safety, emergency warning, and critical communications markets.

In fiscal 2021,2022, we intend to continueare continuing to pursue domestic and international business opportunities with the support of business development consultants, key representatives, and resellers. We plan to grow our revenuesrevenue through increased direct sales to militariesgovernments and large commercial and defense-related companiesagencies that desire to integrate our communication technologies into their product offerings.defense, homeland security and public safety systems. This includes building on fiscal 20202021 domestic defense sales by pursuing further U.S. military opportunities. We also plan to pursue mass notification,emergency warning, public safety and enterprise critical communications, government, law enforcement, fire rescue, homeland and international security, private and commercial security, border security, maritime security, and wildlife preservation business opportunities. In addition

Our research and development strategy involves incorporating further innovations and capabilities into our GEM, IMNS, Zonehaven, NEWS and LRAD products, systems and solutions to meet the matters above, weneeds of our target markets.

Our GEM, IMNS, Zonehaven and NEWS software solutions represent more complex, integrated offerings. We are authorizedpursuing certain certifications, which are often required when bidding on government and mass notification opportunities. We intend to invest engineering resources to enhance our GEM, IMNS, Zonehaven and NEWS software solutions to compete for larger emergency warning and critical communications business opportunities. We are also configuring alternative solutions to achieve lower price points to meet the performanceneeds of servicescertain customers or applications. We also engage in ongoing value engineering to reduce the cost and provisionsimplify the manufacturing of goods pursuant to Delaware General Corporation Law.our products.

 

In March 2020, the World Health Organization ("WHO") classified the COVID-19 outbreak as a pandemic. While the impact of the COVID-19 pandemic did not have a material adverse effect on our financial position or results of operations for the nine months ended June 30, 2021,2022, we monitor the developments and assess areas where there is potential for our business to be impacted. A significant portion of our sales force is working remotely, which could, among other things, negatively impact our ability to engage in sales-related initiatives, or efficiently conduct day-to-day operations. Other businessesBusinesses and governments with which we engage are likelymay be operating under similar restrictions and experiencing disruptions, which may create obstacles in the coordination of business activities, including the negotiation and fulfillment of orders. Disruptions in the supply chain could negatively impact our ability to source materials or manufacture and distribute products. While we do not currently anticipate a material reduction in demand for our commercialized products, we could experience a decrease in new orders, which could negatively impact our revenues and reduce our liquidity and cash flows. Growth in revenue could also be impeded by these factors. The financial markets have been subject to significant volatility that could impact our ability to enter into, modify, and negotiate favorable terms and conditions relative to equity and debt financing activities. We have $14.5$11.7 million in cash and cash equivalents as of June 30, 2021,2022, which we believe provides sufficient capital to fund our operations for at least the next twelve months and withstand the potential near-term consequences of the pandemic, although liquidity constraints and access to capital markets could adversely impact our liquidity and warrant changes to our investment strategy. While we have not yet experienced a material impact, the full magnitude of the pandemic cannot be measured at this time, and therefore, any of the aforementioned circumstances, as well as other factors, may cause our results of operations to vary substantially from year to year and quarter to quarter.

 

Based on various standards published to date, we believe the work our associates perform is critical, essential and life sustaining. We are taking a variety of measures to promote the safety and security of our employees while ensuring the availability and functionality of our critical infrastructure. We are following Center for Disease Control and local guidelines to reduceregarding COVID-19 safety in the transmission of COVID-19, such as the imposition of travel restrictions, cancellation of events, the promotion of social distancing, the adoption of work-from-home arrangements, and limiting access to our facilities. Some or all of these policies and initiatives could impact our operations.workplace. In addition, the following events related to the COVID-19 pandemic could result in lost or delayed revenue to the Company: limitations on the ability of our suppliers to meet delivery requirements and commitments; limitations on the ability of our employees to perform their work due to illness caused by the pandemic, or local, state or federal orders requiring employees to remain at home; limitations on the ability of carriers to deliver our products to customers; unforeseen deviations from customers or foreign governments restricting the ability to do business; and, limitations on the ability of our customers to pay us on a timely basis, if at all.

 

30

A large number of components and sub-assemblies manufactured by outside suppliers within our supply chain are produced within 50 miles of our facility. We do not source a small amount of component parts directly from suppliers in China. ItChina, however, it is also likely that some of our suppliers source parts in China. The COVID-19 pandemic has adversely impacted worldwide supply chains and the ability to obtain sufficient amounts of component parts, including semiconductor chips and integrated circuits, resins, coating and other equipment and components. Negative impacts on our supply chain could have a material adverse effect on our business. We are in contact with our suppliers and evaluating what impact if any, may result from COVID-19.

We have been affected by price increases from our suppliers and logistics as well as other inflationary factors such as increased labor and overhead costs. We regularly review and adjust the sales price of our finished goods to offset these inflationary factors. Although we do not believe that inflation has had a material impact on our financial results through June 30, 2022, sustained or increased inflation in the future may have a negative effect on our ability to achieve certain expectations in gross margin and operating expenses. If we are unable to offset the negative impacts of inflation with increased prices, our future results could be materially affected.

27

 

Critical Accounting Policies

 

We have identified a number of accounting policies as critical to our business operations and the understanding of our results of operations. These are described in our consolidated financial statements located in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended September 30, 2020.2021. The impact and any associated risks related to these policies on our business operations is discussed below and throughout Management’s Discussion and Analysis of Financial Condition and Results of Operations when such policies affect our reported and expected financial results.

 

The methods, estimates and judgments we use in applying our accounting policies, in conformity with U.S. generally accepted accounting principles, have a significant impact on the results we report in our financial statements. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. The estimates affect the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions.

 

Comparison of Results of Operations for the Three Months Ended June 30, 20212022 and 20202021 (in thousands)

 

 

Three Months Ended

         

Three Months Ended

        
 

June 30, 2021

 

June 30, 2020

         

June 30, 2022

 

June 30, 2021

        
     

% of

     

% of

             

% of

     

% of

        
     

Total

     

Total

 

Fav(Unfav)

      

Total

     

Total

 

Fav(Unfav)

 
 

Amount

  

Revenue

  

Amount

  

Revenue

  

Amount

  

%

  

Amount

  

Revenue

  

Amount

  

Revenue

  

Amount

  

%

 

Revenues:

  

Product sales

 $10,719  84.9% $10,933  91.3% $(214) (2.0%) $12,904  91.2% $10,719  84.9% $2,185  20.4%

Contract and other

  1,908  15.1%  1,038  8.7%  870  83.8%  1,248  8.8%  1,908  15.1%  (660) (34.6%)

Total revenues

 12,627  100.0% 11,971  100.0% 656  5.5% 14,152  100.0% 12,627  100.0% 1,525  12.1%
  

Cost of revenues

  5,941  47.0%  5,500  45.9%  (441) (8.0%)  7,572  53.5%  6,206  49.1%  (1,366) (22.0%)

Gross Profit

 6,686  53.0% 6,471  54.1% 215  3.3%

Gross profit

 6,580  46.5% 6,421  50.9% 159  2.5%
  

Operating expenses

  

Selling, general and administrative

 4,776  37.8% 3,330  27.8% (1,446) (43.4%) 5,502  38.9% 4,776  37.8%�� (726) (15.2%)

Research and development

  1,390  11.0%  1,200  10.0%  (190) (15.8%)  1,707  12.1%  1,125  8.9%  (582) (51.7%)

Total operating expenses

  6,166  48.8%  4,530  37.8%  (1,636) (36.1%)  7,209  50.9%  5,901  46.7%  (1,308) (22.2%)
  

Income from operations

 520  4.1% 1,941  16.2% (1,421) (73.2%)

(Loss) income from operations

 (629) (4.4%) 520  4.1% (1,149) (221.0%)
  

Other income (expense)

  (2) (0.0%)  36  0.3%  (38) (105.6%)

Other income (expense), net

  9  0.1%  (2) (0.0%)  11  (550.0%)
  

Income before income taxes

 518  4.1% 1,977  16.5% (1,459) (73.8%)

Income tax expense

  228  1.8%  473  4.0%  245  51.8%

Net income

 $290  2.3% $1,504  12.6% $(1,214) (80.7%)

(Loss) income before income taxes

 (620) (4.4%) 518  4.1% (1,138) (219.7%)

Income tax (benefit) expense

  (31) (0.2%)  228  1.8%  259  113.6%

Net (loss) income

 $(589) (4.2%) $290  2.3% $(879) (303.1%)
  

Net revenue

  

Hardware

 $11,875  94.0% $11,599  96.9% $276  2.4% $13,419  94.8% $11,877  94.1% 1,542  13.0%

Software

  752  6.0%  372  3.1%  380  102.2%  733  5.2%  750  5.9%  (17) (2.3%)

Total net revenue

 $12,627  100.0% $11,971  100.0% $656  5.5% $14,152  100.0% $12,627  100.0% $1,525  12.1%

 

The tables above set forth for the periods indicated certain items of our condensed consolidated statements of operations expressed in dollars and as a percentage of net revenues. The financial information and the discussion below should be read in conjunction with the condensed consolidated financial statements and notes contained in this report.

 

31

Revenues

 

Revenues increased in the current quarter$1,525, or 12.1%, compared towith the same quarter in the prior year. IMNS revenue ($3,894) increased $3,437, while software revenue ($733) decreased $17 and LRAD revenue ($9,525) decreased $1,895, compared with the prior year primarilyquarter. Higher revenue in the third quarter of fiscal 2022 was largely due to the timinglarger backlog at the start of deliveries in backlog as of March 31, 2021, as compared with March 31, 2020. Currentthe fiscal year quarter AHD revenue was $11,420, software revenue was $752 and IMNS revenue was $455. This represented increases of $961, or 9%, for AHD and $380, or 102% for software offset by a decrease of $685, or 60% for IMNS revenue compared with the same prior year period.amount. Software revenue was essentially unchanged, reflecting lower professional services performed in the current quarter, offset by higher recurring software revenue. The receipt of orders is often uneven due to the timing of budget cycles, government budgets or approvals. The increase in software revenue in this year’s period is primarily from professional services revenue on new software contractsfinancial issues and the sale of a software license to one customer.military conflict. As of June 30, 2021,2022, we had aggregate deferred revenue of $1,092$1,340 for extended warranty obligations and software support agreements.

Gross Profit

The increase in gross profit compared with the same period in the prior year was due to higher hardware revenue in this year’s quarter. Gross profit as a percentage of sales was lower compared with the prior year period primarily due to higher costs of components in this year’s quarter.

28

As our products have varying gross margins, product mix may affect gross profits. In addition, our margins vary based on the sales channels through which our products are sold in a given period. We continue to implement product updates and changes, including raw material and component changes, that may impact product costs. We have limited warranty cost experience with product updates and changes and estimated future warranty costs can impact our gross margins. We do not believe that historical gross profit margins should be relied upon as an indicator of future gross profit margins.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased $726, or 15.2%, over the prior year quarter. The increase was largely due to $242 of increased amortization expense, $263 from higher travel, sales and marketing activities, and $124 from higher professional services in the current year period.

We incurred non-cash share-based compensation expenses allocated to selling, general and administrative expenses in the three-months ended June 30, 2022 and 2021 of $327 and $424, respectively.

We may expend additional resources on the marketing and selling of our products in future periods as we identify ways to optimize potential opportunities. Commission expenses will fluctuate based on the nature of our sales.

Research and Development Expenses

Research and development expenses increased $582, or 51.7%, this year as we have more engineers and more engineering time was incurred to increase the features and functionality of our software offering, including the expansion and integration of Zonehaven into the GEM software platform, as compared with the prior year when more time was devoted to professional service contracts.

Included in research and development expenses for the three months ended June 30, 2022 and 2021, was $18 and $12, respectively, of non-cash share-based compensation costs.

Research and development costs vary period to period due to the timing of projects, and the timing and extent of using outside consulting, design and development firms. We seek to continually improve our product offerings, and we expect to continue to expand our product line with new products, customizations and enhancements. Based on current plans, we may expend additional resources on research and development in the current year compared to the prior year.

Net Loss

Net loss in the third quarter of fiscal year 2022 was $589, compared with net income of $290 in the third quarter of fiscal year 2021. The decrease was primarily due to the increased operating expenses resulting from additional engineering, sales and marketing employees.

29

Comparison of Results of Operations for the Nine Months Ended June 30, 2022 and 2021 (in thousands)

  

Nine Months Ended

         
  

June 30, 2022

  

June 30, 2021

         
      

% of

      

% of

         
      

Total

      

Total

  

Fav(Unfav)

 
  

Amount

  

Revenue

  

Amount

  

Revenue

  

Amount

  

%

 

Revenues:

                        

Product sales

 $34,328   90.3% $27,800   87.0% $6,528   23.5%

Contract and other

  3,669   9.7%  4,156   13.0%  (487)  (11.7%)

Total revenues

  37,997   100.0%  31,956   100.0%  6,041   18.9%
                         

Cost of revenues

  19,315   50.8%  16,556   51.8%  (2,759)  (16.7%)

Gross Profit

  18,682   49.2%  15,400   48.2%  3,282   21.3%
                         

Operating expenses

                        

Selling, general and administrative

  16,133   42.5%  11,931   37.3%  (4,202)  (35.2%)

Research and development

  5,314   14.0%  3,089   9.7%  (2,225)  (72.0%)

Total operating expenses

  21,447   56.4%  15,020   47.0%  (6,427)  (42.8%)
                         

(Loss) income from operations

  (2,765)  (7.3%)  380   1.2%  (3,145)  (827.6%)
                         

Other income (expense), net

  12   0.0%  59   0.2%  (47)  (79.7%)
                         

(Loss) income before income taxes

  (2,753)  (7.2%)  439   1.4%  (3,192)  (727.1%)

Income tax (benefit) expense

  (367)  (1.0%)  506   1.6%  873   172.5%

Net loss

 $(2,386)  (6.3%) $(67)  (0.2%) $(2,319)  3461.2%
                         

Net revenues

                        

Hardware

 $36,041   94.9% $29,889   93.5%  6,152   20.6%

Software

  1,956   5.1%  2,067   6.5%  (111)  (5.4%)

Total net revenues

 $37,997   100.0% $31,956   100.0% $6,041   18.9%

Revenues

Revenues increased 18.9% for the nine months ended June 30, 2022, compared with the same prior year period primarily due to the larger backlog as of September 30, 2021 compared with September 30, 2020. LRAD revenue was $27,652 for the current year nine-month period, down $638, or 2.3%, IMNS revenue was $8,389, up $6,790, and software revenue was $1,956, down $111 or 5.4% compared with the same prior year period. The receipt of orders will often be uneven due to the timing of approvals or budgets. As of June 30, 2022, we had aggregate deferred revenue of $1,340 for extended warranty obligations and software support agreements.

 

Gross Profit

 

The increase in gross profit in the quarter compared with the same period in the prior yearnine months ended June 30, 2022 was primarily due to the higher level of revenue.sales volume. Gross profit as a percentage of revenue was lowerhigher compared to the prior year period primarily due to higher revenue and a better mix of revenue in the fiscal 2021 third quarter due to a 61% increase in engineering personnel, primarily software related. Higher software expenses were due to the recent additions of Amika Mobile (through our Canadian subsidiary Genasys Communication Canada) and Zonehaven, and additional employees to support the Australia, EU and enterprise software initiatives.current year.

 

As ourOur products have varying gross margins, so product mix may affect gross profits. In addition, our margins vary based on the sales channels through which our products are sold in a given period. We continue to implement product updates and changes, including raw material and component changes that may impact product costs. With such product updates and changes we have limited warranty cost experience and estimated future warranty costs can impact our gross margins. We do not believe that historical gross profit margins should be relied upon as an indicator of future gross profit margins.

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses increased $1,446,$4,202, or 43%35.2%, overin the nine months ended June 30, 2022 compared with the prior year quarter primarilyperiod. The increase in selling, general and administrative expenses was largely due to a 79%$1,679 increase in sales and marketingcompensation related costs due to a 20% increase in personnel over the prior year, to support future revenue growth opportunities, including opening sales offices$973 increase in Singapore, the United Arab Emirates, and Puerto Rico. Additionalamortization expense, $849 in higher sales and administrative personnel were added through two acquisitions this fiscal year.marketing activities and travel, and a $445 increase in commission expense.

 

We incurred non-cash share-based compensation expenses allocated to selling, general and administrative expenses in the three-monthsnine months ended June 30, 2022 and 2021 of $1,544 and 2020 of $424 and $311,$904, respectively.

 

We may expend additional resources on the marketing and selling of our products in future periods as we identify ways to optimize potential opportunities, including the June 2022 European Public Warning Systems mandate and enterprise software services.opportunities. Commission expenses will fluctuate based on the nature of our sales.

30

 

Research and Development Expenses

 

Research and development expenses increased $190 compared with$2,225, or 72%, as we increased our engineering team and increased engineering time was utilized to increase software functionality and features, including the same quarter inexpansion and integration of Zonehaven into the prior year. The higher cost was due to increases in engineering personnel and expending more engineering labor in support of development activities compared to the prior year period.GEM software platform.

 

Included inWe incurred non-cash share-based compensation expenses allocated to research and development expenses forin the threenine months ended June 30, 2022 and 2021 of $53 and 2020, was $12 and $6, respectively, of non-cash share-based compensation costs.$28, respectively.

 

Research and development costs vary period to period due to the timing of projects, the amount of support provided on customer projects, and the timing and use of outside consulting, design, and development firms. We continually improve our product offerings, and we expect to continue to expand our product line with new products, customizations, and enhancements. Based on current plans, we may expend additional resources on research and development in the current year compared to the prior year.

 

Net Income

Net income in the third quarter of fiscal year 2021 was $290, a decrease of $1,214 compared with the third quarter of fiscal year 2020. The decrease was primarily due to increased selling, general and administrative expenses, offsetting the higher revenue and gross profit in the third quarter of fiscal year 2021.

32

Comparison of Results of Operations for the Nine Months Ended June 30, 2021 and 2020 (in thousands)

  

Nine Months Ended

         
  

June 30, 2021

  

June 30, 2020

         
      

% of

      

% of

         
      

Total

      

Total

  

Fav(Unfav)

 
  

Amount

  

Revenue

  

Amount

  

Revenue

  

Amount

  

%

 

Revenues:

                        

Product sales

 $27,800   87.0% $26,494   91.3% $1,306   4.9%

Contract and other

  4,156   13.0%  2,535   8.7%  1,621   63.9%

Total revenues

  31,956   100.0%  29,029   100.0%  2,927   10.1%
                         

Cost of revenues

  16,229   50.8%  13,946   48.0%  (2,283)  (16.4%)

Gross Profit

  15,727   49.2%  15,083   52.0%  644   4.3%
                         

Operating expenses

                        

Selling, general and administrative

  11,931   37.3%  8,884   30.6%  (3,047)  (34.3%)

Research and development

  3,416   10.7%  3,233   11.1%  (183)  (5.7%)

Total operating expenses

  15,347   48.0%  12,117   41.7%  (3,230)  (26.7%)
                         

Income from operations

  380   1.2%  2,966   10.2%  (2,586)  (87.2%)
                         

Other income

  59   0.2%  202   0.7%  (143)  (70.8%)
                         

Income before income taxes

  439   1.4%  3,168   10.9%  (2,729)  (86.1%)

Income tax expense

  506   1.6%  742   2.6%  236   31.8%

Net (loss) income

 $(67)  (0.2%) $2,426   8.4% $(2,493)  (102.8%)
                         

Net revenue

                        

Hardware

 $29,887   93.5% $27,820   95.8% $2,067   7.4%

Software

  2,069   6.5%  1,209   4.2%  860   71.1%

Total net revenue

 $31,956   100.0% $29,029   100.0% $2,927   10.1%

The tables above set forth for the periods indicated certain items of our condensed consolidated statements of operations expressed in dollars and as a percentage of net revenues. The financial information and the discussion below should be read in conjunction with the condensed consolidated financial statements and notes contained in this report.

Revenues

Revenues increased 10% for the nine-month period ended June 30, 2021, compared with the same prior year period primarily due to the timing for delivery of the backlog at September 30, 2020 compared with the September 30, 2019 backlog. AHD revenues were $28,288 for the current year nine-month period, up $2,789, or 11%, IMNS revenue was $1,599, down $722, or 31%, and software revenue was $2,069, up $860, or 71%, compared with the same prior year period. The receipt of orders will often be uneven due to the timing of approvals or budgets. As of June 30, 2021, we had aggregate deferred revenue of $1,092 for extended warranty obligations and software support agreements.

Gross Profit

The increase in gross profit in the nine months ended June 30, 2021, was primarily due to higher sales volume. Gross profit as a percentage of revenue was lower compared to the prior year period primarily due to a 64% increase in engineering personnel, primarily software related. Higher software expenses were due to the recent additions of Amika Mobile (through our Canadian subsidiary Genasys Communications Canada) and Zonehaven, and additional employees to support the Australia, EU and enterprise software initiatives.

As our products have varying gross margins, product mix may affect gross profits. In addition, our margins vary based on the sales channels through which our products are sold in a given period. We continue to implement product updates and changes, including raw material and component changes that may impact product costs. With such product updates and changes we have limited warranty cost experience and estimated future warranty costs can impact our gross margins. We do not believe that historical gross profit margins should be relied upon as an indicator of future gross profit margins.

33

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased $3,047 in the nine months ended June 30, 2021, compared with the prior year period. The increase in selling, general and administrative expenses was primarily due to a 60% increase in sales and marketing personnel over the prior year to support future business and revenue growth opportunities.

We incurred non-cash share-based compensation expenses allocated to selling, general and administrative expenses in the nine months ended June 30, 2021, and 2020, of $904 and $738, respectively.

We may expend additional resources on the marketing and selling of our products in future periods as we identify ways to optimize potential opportunities. Commission expenses will fluctuate based on the nature of our sales.

Research and Development Expenses

Research and development expenses increased $183. The higher costs were due to increases in engineering personnel and expending more engineering labor in support of development activities compared to the prior year period.

Included in research and development expenses for the nine months ended June 30, 2021, and 2020, were $28 and $22 of non-cash share-based compensation costs, respectively.

Research and development costs vary period to period due to the timing of projects, the amount of support provided on customer projects, and the timing and use of outside consulting, design and development firms. We continually improve our product offerings and we expect to continue to expand our product line with new products, customizations and enhancements. Based on current plans, we may expend additional resources on research and development in the current year compared to the prior year.

Net Loss/IncomeLoss

 

Net loss of $67was $2,386 for the first nine months of fiscal year 2021, was a decrease of $2,4932022 compared with a $67 net incomeloss in the prior year period. This decrease was primarily due to the higher operating expenses, partially offset by the higher revenue and gross profit in the current year period.

Other Metrics

We monitor a number of financial and operating metrics, including adjusted EBITDA, to evaluate our business, measure our performance, identify trends affecting our business, formulate business plans and make strategic decisions. Our business metrics may be calculated in a manner different than similar other business metrics used by other companies (in thousands):

Adjusted EBITDA

Adjusted EBITDA represents our net income before other income, net income tax expense (benefit), depreciation and amortization expense, and stock-based compensation. We do not consider these items to be indicative of our core operating performance. The items that are non-cash include depreciation and amortization expense and stock-based compensation. Adjusted EBITDA is a measure used by management to understand and evaluate our core operating performance and trends, and to generate future operating plans, make strategic decisions regarding allocation of capital, and invest in initiatives focused on cultivating new markets for our solutions. In particular, the exclusion of certain expenses in calculating adjusted EBITDA facilitates comparisons of our operating performance on a period-to-period basis. Adjusted EBITDA is not a measure calculated in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). We believe that adjusted EBITDA provides useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and board of directors. Nevertheless, use of adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our financial results as reported under U.S. GAAP. Some of these limitations are: (1) although depreciation and amortization are non-cash charges, the intangible assets that are amortized and property and equipment that is depreciated, will need to be replaced in the future, and adjusted EBITDA does not reflect cash capital expenditure requirements for such replacement or for new capital expenditure requirements; (2) adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs; (3) adjusted EBITDA does not reflect the potentially dilutive impact of equity-based compensation; (4) adjusted EBITDA does not reflect tax payments or receipts that may represent a reduction or increase in cash available to us; and (5) other companies, including companies in our industry, may calculate adjusted EBITDA or similarly titled measures differently, which reduces the usefulness of the metric as a comparative measure. Because of these and other limitations, you should consider adjusted EBITDA alongside our other U.S. GAAP-based financial performance measures, net income and our other U.S. GAAP financial results.

The following table presents a reconciliation of adjusted EBITDA to net income, the most directly comparable U.S. GAAP measure, for each of the periods indicated (in thousands):

  

Three months ended

  

Nine months ended

 
  

June 30,

  

June 30,

 
  

2022

  

2021

  

2022

  

2021

 

Net (loss) income

 $(589) $290   (2,386)  (67)

Other (income) expense, net

  (9)  2   (12)  (59)

Income tax (benefit) expense

  (31)  228   (367)  506 

Depreciation and amortization

  638   401   1,920   953 

Stock-based compensation

  355   446   1,650   956 

Adjusted EBITDA

 $364  $1,367  $805  $2,289 

31

 

Liquidity and Capital Resources

 

The Company’s financial condition and liquidity remain strong. Cash and cash equivalents as of June 30, 2021,2022 was $14,540,$11,723, down $8,779,$1,444 compared with $23,319$13,167 as of September 30, 2020.2021. We had short-term marketable securities of $5,976$5,270 as of June 30, 2021,2022, compared with $4,265$5,686 as of September 30, 2020.2021. We had long-term marketable securities of $2,297$2,004 as of June 30, 2021,2022, compared with $3,805$1,875 as of September 30, 2020.2021. In addition we have a $10 million line of credit with MUFG bank. As of June 30, 2021, the Company had no outstanding balances against the line of credit. The credit agreement requires the Company to comply with various financial and operating covenants and as of June 30, 2021, the Company was in compliance with these covenants. Other than cash and cash equivalents, short and long-term marketable securities, other working capital and expected future cash flows from operating activities in subsequent periods, and thewe have a $10 million revolving line of credit we have no unused sourcesavailable as a source of liquidity at this time.liquidity.

 

Although there is uncertainty related to the anticipated impact of the recent COVID-19 outbreak on the Company’s future results, we believe our efficient business model and strong balance sheet keep us positioned to manage our business through this crisis as it continues to unfold. We continue to manage all aspects of our business including, but not limited to, monitoring the financial health of our customers, suppliers and other third-party relationships and developing new opportunities for growth.

 

Principal factors that could affect our liquidity include:

•         ability to meet sales projections;

•         government spending levels;

•         introduction of competing technologies;

•         product mix and effect on margins;

•         ability to reduce current inventory levels;

•         product acceptance in new markets;

•         value of shares repurchased;

•         value of dividends declared;

•         supply chain disruptions;

•         inflation;

•         conflict between Russia and Ukraine;

•         impact of COVID-19 on global market conditions; and

•         impact of COVID-19 on customers’ ability to pay.

 

Principal factors that could affect our ability to obtain cash from external sources include:

•         volatility in the capital markets; and

•         market price and trading volume of our common stock.

34

 

Based on our current cash position, and assuming currently planned expenditures and level of operations, we believe we have sufficient capital to fund operations for the twelve-month period subsequent to the issuance of the interim financial information. However, we operate in a rapidly evolving and unpredictable business environment that may change the timing or amount of expected future cash receipts and expenditures. Accordingly, there can be no assurance that we may not be required to raise additional funds through the sale of equity or debt securities or from credit facilities. Additional capital, if needed, may not be available on satisfactory terms, or at all.

 

Cash Flows

 

Our cash flows from operating, investing and financing activities, as reflected in the condensed consolidated statements of cash flows, are summarized in the table below:

 

 

Nine months ended

  

Nine months ended

 
 

June 30, 2021

  

June 30, 2020

  

June 30, 2022

  

June 30, 2021

 

Cash provided by (used in):

  

Operating activities

 $8,314  $3,711  $(571) $8,314 

Investing activities

 $(16,237) $(2,425) 14  (16,237)

Financing activities

 $(27) $540  (1,092) (27)

 

Operating Activities

Net loss of $2,386 for the nine months ended June 30, 2022 was decreased by $4,006 of non-cash items that included share-based compensation, depreciation and amortization, amortization of operating lease ROU assets, an increase to deferred income taxes, warranty provision and inventory obsolescence. Cash used by operating activities in the current year reflected an increase in inventory of $2,563, and a decrease in accrued liabilities and other of $3,012, comprised of a decrease in the balances of customer deposits received, and payment of incentive compensation earned in fiscal year 2021. This was offset by a $1,964 decrease in accounts receivable, a $1,049 decrease in prepaid expenses, and a $371 increase in accounts payable.

32

 

Net loss of $67 for the nine months ended June 30, 2021 was offset by $3,257 of non-cash items that included depreciation and amortization, share-based compensation, operating lease ROU asset amortization, warranty provision, inventory obsolescence, both realized and unrealized loss on a foreign currency forward contract, and a reduction to deferred income taxes. Cash provided by operating activities for the currentprior year reflected an increase of $1,134 in accounts payable, primarily for inventory related purchases, and a $5,988 increase in accrued and other liabilities, primarily from a $7,410 increase in customer deposits resulting from increased hardware orders, received thisin the prior fiscal year offset by a $630 reduction to accrued contract costs. Cash used in operating activities for the nine months ended June 30, 2021, reflected a $788 increase in inventory, a $636 increase in prepaid expense, and a $574 increase in accounts receivable.

 

Net income of $2,426 for the nine months ended June 30, 2020, was increased by $2,755 of non-cash items that included a reduction to deferred income taxes, share-based compensation, depreciation and amortization, warranty provision, amortization of operating right of use assets, and inventory obsolescence. Cash used in operating activities as of June 30, 2020, reflected an increase in accounts receivable of $2,722 due to higher sales with net credit terms in the quarter compared with the fourth quarter of fiscal 2019 and an increase in inventory of $1,667 to support the current backlog. Cash provided by operating activities included an increase in accounts payable of $2,040, primarily for inventory related purchases, a decrease in prepaid expenses and other of $732, and an increase in accrued liabilities of $148.

We had accounts receivable of $6,270$5,691 as of June 30, 2021,2022, compared with $5,442 at$7,682 as of September 30, 2020.2021. Terms with individual customers vary greatly. We regularly provide thirty-day terms to our customers if credit is approved. Our receivables can vary dramatically due to overall sales volume, quarterly variations in sales, timing of shipments to and receipts from large customers, payment terms, and the timing of contract payments.

 

As of June 30, 2021,2022 and September 30, 2020,2021, our working capital was $17,764$17,613 and $29,796,$18,019, respectively. The decrease in working capital was primarily due to the net loss this period, change in the short-term/long-term mix of marketable securities, and the use of cash to complete the Amika Mobile asset purchase and Zonehaven acquisition in the first and third quarters respectivelyrepurchase shares of fiscal year 2021.Company stock.

 

Investing Activities

 

Our net cash provided by investing activities was $14 for the nine months ended June 30, 2022, compared with net cash used in investing activities wasof $16,237 for the nine months ended June 30, 2021, compared with cash used in investing activities of $2,425 for the nine months ended June 30, 2020.2021. In the first nine months of fiscal 2021, $15,848 was used for acquisitions. In the first nine months of fiscal 2021,2022, we increaseddecreased our holdings ofin short and long-term marketable securities by $208,$205 compared with an increase of $2,314 in$208 for the nine months endedending June 30, 2020.2021.  Cash used in investing activities for the purchase of property and equipment was $181$191 and $111$181 for the nine months ended June 30, 2021,2022, and 2020,2021, respectively. We anticipate additional expenditures for tooling and equipment during the balance of fiscal year 2021.2022. During the first nine months of fiscal 2021, $15,848 was used for acquisitions. 

 

Financing Activities

 

In the nine months ended June 30, 2021,2022, we used $27$1,092 for financing activities compared with $540 provided by financing activities$27 for the nine months ended June 30, 2020.2021. In the first nine months of fiscal 2022 we received $253 from the exercise of stock options and used $998 to repurchase shares of our common stock, $70 to settle statutory tax withholding requirements upon vesting of restricted stock units and $277 in the repayment of promissory notes upon the certification of completed projects by goverenment agencies in Spain. In the first nine months of fiscal year 2021, we received $170 from the exercise of stock options, which was offset by $141 of cash used to settle statutory tax withholding requirements on behalf of our employees upon vesting of restricted stock awards. Duringawards, $18 in payments on promissory notes, and $38 of cash paid in connection with the first nine monthsestablishment of fiscal 2020, proceeds from the exerciseour $10 million line of stock options were $996 and we used $398 to repurchase company common stock.credit.

35

 

In December 2018, the Board of Directors approved a new share buyback program beginning January 1, 2019, under which the Company was authorized to repurchase up to $5 million of its outstanding common shares. In December 2020, the board voted to extend this program’s expiration date to December 31, 2022. During the quarternine months ended June 30, 2021, no2022, 259,310 shares were repurchased. Duringpurchased for $998. No shares were repurchased during the quarternine months ended June 30, 2020, no2021. All repurchased shares were repurchased. Ashave been retired and as of June 30, 2021, all repurchased shares were retired. As of June 30, 2021, $4.12022, $3.0 million was available for share repurchase under this program. In December 2020, the board extended this program’s expiration date to December 31, 2022.

 

Recent Accounting Pronouncements

 

New pronouncements issued for future implementation are discussed in Note 3, Recent Accounting Pronouncements, to our condensed consolidated financial statements.

 

Item3.Quantitative and Qualitative Disclosures about Market Risk.

Quantitative and Qualitative Disclosures about Market Risk.

 

Foreign Currency Risk

We consider our direct exposure to foreign exchange rate fluctuations to be minimal. The transactions of our Spanish subsidiary are denominated primarily in Euros and the transactions of our Canadian subsidiary are denominated primarily in Canadian dollars, which is a natural hedge against foreign currency fluctuations. Currency translation gains and losses are primarily related to our Spanish and Canadian subsidiaries, whereby assets and liabilities are translated from the respective functional currency into U.S. dollars using period-end exchange rates, which impacts other comprehensive income.

All other sales to customers and all arrangements with third-party manufacturers, with one exception, provide for pricing and payment in U.S. dollars, and, therefore, are not subject to exchange rate fluctuations. Increases in the value of the U.S. dollar relative to other currencies could make our products more expensive, which could negatively impact our ability to compete. Conversely, decreases in the value of the U.S. dollar relative to other currencies could result in our suppliers raising their prices to continue doing business with us. Fluctuations in currency exchange rates could affect our business in the future.

 

33

Item4.Controls and Procedures.

Controls and Procedures.

 

We are required to maintain disclosure controls and procedures designed to ensure that material information related to us, including our consolidated subsidiaries, is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms.

 

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer, we conducted an evaluation of our disclosure controls and procedures as such term is defined under Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934. Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of June 30, 2021.2022.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting during our fiscal quarter ended June 30, 2021,2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Our process for evaluating controls and procedures is continuous and encompasses constant improvement of the design and effectiveness of established controls and procedures and the remediation of any deficiencies, which may be identified during this process.

 

Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

PART II. OTHER INFORMATION

Item 1.Legal Proceedings.

Legal Proceedings.

 

We may at times be involved in litigation in the ordinary course of business. We will also, from time to time, when appropriate in management’s estimation, record adequate reserves in our consolidated financial statements for pending litigation. Currently, there are no pending material legal proceedings to which the Company is a party or to which any of its property is subject.

 

36

Item1A.Risk Factors.

Risk Factors.

 

There have been no material changes to the risk factors described under Item 1A of our Annual Report on Form 10-K for the fiscal year ended September 30, 2020,2021, filed with the SEC on December 10, 2020,November 23, 2021, except for those noted below:

 

Supply chain disruptions. The COVID-19 pandemic has adversely impacted worldwide supply chainsconflict between Russia and Ukraine and the abilityrelated implications may negatively impact our operations.

In February 2022, Russia invaded Ukraine. As a result, the U.S. and certain other countries have imposed sanctions on Russia and could impose further sanctions, as well as potential retaliatory actions by Russia, that could damage or disrupt international commerce and the global economy. It is not possible to obtain sufficient amountspredict the broader or longer-term consequences of component parts, including semiconductor chipsthis conflict or the impact of sanctions, embargoes, regional instability, geopolitical shifts and integrated circuits, resins, coatingadverse effects on macroeconomic conditions, security conditions, currency exchange rates and other equipmentfinancial markets. Such geopolitical instability and components. Negative impacts on our supply changeuncertainty could have a materialnegative impact on our ability to sell, ship products, collect payments, and support customers in certain regions based on trade restrictions, embargoes and export control law restrictions, supply disruptions, and logistics restrictions including closures of air space, and could increase the costs, risks and adverse impacts from supply chain and logistics challenges.

The potential effects of the conflict between Russia and Ukraine also could impact many of the other risk factors described in Item 1A, Risk Factors, in our Annual Report on Form 10-K for the fiscal year ended September 30, 2021. Given the evolving nature of this conflict, the related sanctions, potential governmental actions and economic impact, such potential impacts remain uncertain. While we expect the impacts of conflict between Russia and Ukraine could have an effect on our business.business, financial condition and results of operations, we are unable to predict the extent or nature of these impacts at this time.

 

Reference rate reformRisks related to global economic instability, including global supply chain issues, inflation, labor costs, and fuel and energy costs, may affect the Companys business. Borrowings under

The increasingly volatile global economic environment has created market uncertainty. A slowdown in the financial markets or other economic conditions including but not limited to global supply chain issues, inflation, fuel and energy costs, freight costs, lack of available credit, interest rates, and tax rates, may adversely affect the Company’s growth and profitability.  Fluctuation of prices and availability of commodities and materials used in the manufacture of our credit facility with MUFG Union Bank, N.A. will bear an interest rate based on certain tenorsproducts may affect the cost of operations.  In addition, increasing wage inflation and challenges hiring qualified personnel may impact our ability to meet customer demand. 

34

The potential effects of market uncertainty and inflation could also impact many of the London interbank offered rate (“LIBOR”) plus a credit spread. In July 2017, the United Kingdom’s Financial Conduct Authority, which regulates LIBOR, announced that, after 2021, it will stop compelling banks to submit ratesother risk factors described in Item 1A, Risk Factors, in our Annual Report on Form 10-K for the calculationfiscal year ended September 30, 2021. While we expect the impacts of LIBOR. The discontinuation, reform,market uncertainty and inflation could have an effect on our business, financial condition and results of operations, we are unable to predict the extent or replacementnature of LIBOR could result in interest rate increases, which could adversely affect our cash flows and operating results.these impacts at this time.

 

Zonehaven acquisition. Our ability to recognize the expected synergies and other benefits of the Zonehaven acquisition, difficulties in integrating Zonehaven post-closing, diversion of management time addressing post-closing transaction-related issues, uncertainties related to litigation involving the acquisition of Zonehaven, uncertainties related to unanticipated integration costs or undisclosed liabilities assumed, uncertainties related to the acceptance of the Zonehaven acquisition and its products by third parties.

ItemItem2.Unregistered Sales of Equity Securities and Use of Proceeds.

Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

ItemItem3.Defaults Upon Senior Securities.

Defaults Upon Senior Securities.

 

None.

 

ItemItem4.Mine Safety Disclosures.

Mine Safety Disclosures.

 

Not Applicable.

 

Item5.Other Information.

Other Information.

 

None.

 

ItemItem6.Exhibits.

Exhibits.

 

2.1

Agreement and Plan of Merger dated as of June 7, 2021, among Genasys Inc., ZH Acquisition I Inc., ZH Acquisition II Inc., Zonehaven Inc., and Charles Crocker in his capacity as Seller Representative. Incorporated by reference to Exhibit 2.1 to Current Report on Form 8-K filed on June 10, 2021. 

31.1

Certification of Richard S. Danforth, Principal Executive Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

  

31.2

Certification of Dennis D. Klahn, Principal Financial Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

  

32.1

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Richard S. Danforth, Principal Executive Officer and Dennis D. Klahn, Principal Financial Officer.*

  

101.INS

Inline XBRL Instance Document (the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)Document*

  

101.SCH

Inline XBRL Taxonomy Extension Schema Document*

  

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document*

  

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document*

  

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document*

  

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document*

  
104Cover Page Interactive Data File (formatted as(embedded within the Inline XBRL and contained in Exhibit 101)


*         Filed concurrently herewith.

Filed concurrently herewith

 


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

GENASYS INC.

   

Date: July 28, 2021August 11, 2022

By: 

/s/    Dennis D. Klahn

  

Dennis D. Klahn, Chief Financial Officer

  

(Principal Financial Officer)

 

3836